0000950170-23-001616.txt : 20230201 0000950170-23-001616.hdr.sgml : 20230201 20230201170046 ACCESSION NUMBER: 0000950170-23-001616 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20230201 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230201 DATE AS OF CHANGE: 20230201 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CORE LABORATORIES N V CENTRAL INDEX KEY: 0001000229 STANDARD INDUSTRIAL CLASSIFICATION: OIL, GAS FIELD SERVICES, NBC [1389] IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-14273 FILM NUMBER: 23577695 BUSINESS ADDRESS: STREET 1: VAN HEUVEN GOEDHARTLAAN 7 B CITY: 1181 LE AMSTELVEEN STATE: P7 ZIP: 1181 LE BUSINESS PHONE: 3124203191 MAIL ADDRESS: STREET 1: 6316 WINDFERN CITY: HOUSTON STATE: TX ZIP: 77040 8-K 1 clb-20230201.htm 8-K 8-K
0001000229false00-000000000010002292023-02-012023-02-01

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 1, 2023

 

CORE LABORATORIES N.V.

(Exact name of registrant as specified in its charter)

 

 

The Netherlands

001-14273

Not Applicable

(State or Other Jurisdiction

of Incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

 

 

 

Van Heuven Goedhartlaan 7 B
1181 LE Amstelveen
The Netherlands

 

Not Applicable

(Address of Principal Executive Offices)

 

(Zip Code)

Registrant’s Telephone Number, Including Area Code: (31-20) 420-3191

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange on which registered

Common Stock (Par Value EUR 0.02)

 

CLB

 

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

Item 2.02 Results of Operations and Financial Condition.

On February 1, 2023, Core Laboratories N.V. issued a press release announcing its financial results for the fourth quarter of 2022 and year ending December 31, 2022.

Item 7.01 Regulation FD Disclosure.

On February 1, 2023, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.01 per share of common stock for shareholders of record on February 13, 2023 and payable March 6, 2023.

The full text of the press release is set forth in Exhibit 99.1 attached hereto.

The information in this Report and the exhibit attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly stated by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d)

 

Exhibits

99.1 Press release issued on February 1, 2023 *

104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

* This exhibit is intended to be furnished and shall not be deemed "filed" for purposes of the Exchange Act.

 

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

 

 

 

 

 

 

Core Laboratories N.V.

 

 

 

 

 

 

 

Dated: February 1, 2023

 

By

 

/s/ Christopher S. Hill

 

 

 

 

 

 

Christopher S. Hill

 

 

 

 

 

 

Chief Financial Officer

 

 

 

 

 

 

 EX-99.1 2 clb-ex99_1.htm EX-99.1 EX-99.1

Exhibit 99.1

 

img77179564_0.jpg  

 

FOR IMMEDIATE RELEASE

CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2022 RESULTS FROM CONTINUING OPERATIONS:

•
FOURTH QUARTER REVENUE OF $128 MILLION; UP SLIGHTLY SEQUENTIALLY
•
FOURTH QUARTER OPERATING INCOME OF $16 MILLION; EX-ITEMS OF $15 MILLION, UP 10% SEQUENTIALLY
•
FOURTH QUARTER OPERATING MARGIN, EX-ITEMS, OF 12% WITH SEQUENTIAL INCREMENTAL MARGINS EXCEEDING 80%, DRIVEN BY PRODUCTION ENHANCEMENT
•
FOURTH QUARTER GAAP EPS OF $0.14; EX-ITEMS, $0.20
•
FOURTH QUARTER CASH FROM OPERATIONS OF $13.2 MILLION
•
FOURTH QUARTER FREE CASH FLOW OF $11.2 MILLION
•
FOURTH QUARTER NET DEBT REDUCED BY $11.7 MILLION SEQUENTIALLY
•
COMPANY ANNOUNCED DELISTING FROM EURONEXT AND REDOMESTICATION TO THE U.S.
•
COMPANY ANNOUNCES Q1 2023 QUARTERLY DIVIDEND

AMSTERDAM (1 February 2023) - Core Laboratories N.V. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported fourth quarter 2022 revenue of $127,600,000. Core’s operating income was $15,600,000, with diluted earnings per share ("EPS") of $0.14, all in accordance with U.S. generally accepted accounting principles ("GAAP"). The financial results for the fourth quarter of 2022 include a non-cash adjustment of $1,900,000, decreasing stock compensation expense associated with performance share awards that vested during the quarter. Operating income, ex-items, a non-GAAP financial measure, was $14,700,000, yielding operating margins of 12%, and EPS, ex-items, of $0.20. A full reconciliation of non-GAAP financial measures is included in the attached financial tables.

 

For 2022, Core’s revenue of $489,700,000 increased 4% from the prior year. Core’s full-year revenue was adversely impacted by the devaluation of the Euro and British Pound when translated into U.S. dollars. Using a constant U.S. dollar exchange rate, 2022 revenue would have been approximately $12,800,000 higher. In addition, Core’s 2022 revenue was also adversely impacted by the Russia-Ukraine conflict. Across Core’s European, Russian and Ukrainian operations, activity declined due to disruptions in crude-oil trading patterns, causing the Company’s crude-oil assay and derived product testing revenue and product sales to decline in excess of $10,000,000 year-over-year. The combined impact of these currency fluctuations and geopolitical factors adversely impacted 2022 revenue by approximately $22,800,000 year-over-year, substantially offsetting international growth in other regions.

 

Core’s CEO, Larry Bruno stated, “First, our thoughts remain with our Ukrainian employees and their families during the on-going conflict. Despite the challenges posed by currency and geopolitical conflict, Core's

 

 

results during the fourth quarter of 2022 displayed continued positive momentum, as we achieved sequential improvement in revenue, operating income, operating margins and EPS, with strong incremental margins. These improvements translated into higher free cash flow (“FCF”), which enabled the Company to decrease net debt by $11,700,000 or 7%, sequentially. Core remains intently focused on executing against its key financial and operational strategies, including 1) reducing debt and strengthening our balance sheet, as well as 2) consistently pursuing efficiencies and the introduction of new technologies. For 2023, Core sees the continuation of a multi-year recovery cycle for the oil and gas industry led by improvement in both onshore and offshore client activity across our global operations, although the Russia-Ukraine conflict continues to create volatility and uncertainties to growth prospects in Europe, Russia and Ukraine."

 

Voluntary Delisting from Euronext and Redomestication to the United States

 

On 4 November 2022, Core Lab announced its decision to voluntarily delist its shares from Euronext Amsterdam, and the last trading day for the Company’s shares on the Euronext was 2 December 2022. The Company’s shares continue to trade on the New York Stock Exchange under the symbol “CLB”.

 

Following the delisting of the shares, on 17 January 2023, Core Lab announced plans to reorganize the Company’s corporate structure, resulting in the redomestication of the parent company from the Netherlands to the United States (the “Redomestication”). The Company and its Board believes that the Redomestication will enhance shareholder value over the long-term through simplifying the corporate structure, improving operational efficiencies and reducing administrative costs. The Redomestication, if approved by the Company's shareholders, will change the Company’s jurisdiction of organization from the Netherlands to the State of Delaware.

 

Benefits of the Redomestication include: (i) a reduction in the corporate footprint and regulatory requirements associated with preparing duplicative audited financial statements and other reporting obligations, (ii) improved efficiencies and opportunities in the Company’s corporate treasury, cash management, risk management and tax functions, and (iii) a simplified and more efficient tax structure.


Reservoir Description

 

Reservoir Description operations are closely correlated with trends in international and offshore activity levels, with approximately 80% of revenue sourced from projects originating outside the U.S. Reservoir Description revenue in the fourth quarter of 2022 was $78,100,000, down slightly sequentially and year-over-year. Geopolitical sanctions that became effective during the fourth quarter of 2022, further disrupted trading patterns of crude oil and derived products in Europe, Russia and Ukraine. As a result, the demand for laboratory services in the fourth quarter of 2022 was adversely impacted, offsetting revenue growth in other international regions. Operating income for the fourth quarter of 2022 on a GAAP basis was $6,800,000, while operating income, ex-items, was $6,000,000, yielding operating margins of 8%.

 

Reservoir Description revenue for 2022 was adversely impacted by the devaluation of the Euro and British Pound when translated into U.S. dollars. Using a constant U.S. dollar exchange rate, Reservoir Description 2022 revenue would have been approximately $12,000,000 higher. For 2022, revenue was also adversely impacted by the Russia-Ukraine conflict, declining over $9,000,000 compared to 2021. Combined, these

 

 

two factors adversely impacted Reservoir Description 2022 revenue by approximately $21,000,000, substantially offsetting international growth in other regions.

 

During the fourth quarter of 2022, under the direction of a South American National Oil Company, Core Lab conducted a series of Enhanced Oil Recovery (“EOR”) and flow assurance studies for a multi-well onshore program using CO2-rich injection gases. The studies determined the impact of blending these CO2-rich gases with reservoir fluids and provided the basis for advanced equation-of-state modelling. While defining the gas injection parameters for a successful field application are critical to improving crude oil recoveries, operators must simultaneously mitigate the flocculation of asphaltenes that result from CO2 injection, and which, can erase such gains. CO2 injection projects reflect a globally expanding interest in EOR and Carbon Capture and Storage technologies. When properly evaluated with rigorous laboratory testing, injecting CO2 into hydrocarbon-bearing subsurface formations can simultaneously improve oil recovery and reduce CO2 emissions.

 

Also, during the fourth quarter of 2022, Core received both reservoir fluid and reservoir rock samples from Talos Energy Inc.’s Deepwater Gulf of Mexico Lime Rock and Venice prospects. Leveraging Core’s experience with prior successful Gulf of Mexico drilling campaigns, the Company was able to quickly implement laboratory analytical protocols to fast-track results and evaluate reservoir potential within days of receiving the samples. The analytical results provided key reservoir parameters including: 1) an assessment of the pore system and fluid flow properties of these high-quality sandstone strata, 2) measurement of the crude oil and natural gas saturations in the recovered rocks, and 3) determination of key reservoir fluid properties such as the gas-oil ratio, and with the composition of the hydrocarbons. Talos’ experts incorporated these parameters into their assessment of the commercial viability of these prospects. Core’s proprietary high pressure, high temperature, full visualization Pressure-Volume-Temperature technologies, along with the Company's extensive database of producing reservoirs in the Gulf of Mexico, helped Talos in this successful drilling program.

 

Production Enhancement

 

Production Enhancement operations, which are focused on complex completions in unconventional, tight-oil reservoirs in the U.S., as well as conventional projects across the globe, posted fourth quarter 2022 revenue of $49,400,000, increasing over 5% sequentially and 10% year-over-year. Operating income on a GAAP basis was $7,900,000, while operating income, ex-items, was $7,700,000, yielding operating margins of 16% and sequential incremental margins, ex-items, in excess of 100%. In addition, Core’s proprietary diagnostic services grew over 22% sequentially and 17% year-over-year.

 

During the fourth quarter of 2022, a U.S.-based operating company expressed the need to overcome injectivity challenges in their saltwater disposal wells. Cost-effective disposal of produced frac fluid is critical to the financial success of unconventional resources. Reservoir modeling determined that to optimize injection efficiencies, 14 zones dispersed across a 1,700 ft lateral wellbore needed to be perforated simultaneously in an over-balanced pressure configuration. Core Lab provided a customized solution for this challenging technical problem by combining its proprietary Pulse Wave™ Tubular Conveyed System with its proprietary HERO® Hard Rock energetics. Pulse Wave™ uses a unique energy transfer technology that can trigger multiple, unevenly-spaced perforating guns in a single downhole trip, eliminating the need for inert spacer guns between live guns to create a continuous communication string.

 

 

Eliminating the need for spacer guns reduces material cost and significantly reduces the rig time required to deploy the system. The HERO® Hard Rock energetic technology uses an advanced, patented, liner material technology that yields debris-free perforations, while also providing deep penetration and more effective flow efficiencies in hard rock formations. By employing Pulse Wave™ technology, the client saved over 30% on the cost of consumables, in addition to reduced rig time. The HERO® Hard Rock energetics created communication across each perforating interval, enabling the operator to establish the desired injection rate, which was double that of similar wells completed using conventional wireline perforating technologies.

 

Liquidity, Free Cash Flow and Dividend

 

Core continues to focus on maximizing FCF, a non-GAAP financial measure defined as cash from operations less capital expenditures. For the fourth quarter of 2022, cash from operations was $13,200,000 and capital expenditures were $2,000,000, yielding FCF of $11,200,000. Core’s free cash will continue to be returned to its shareholders through the Company’s regular quarterly dividend as well as being focused towards reducing long-term debt.

 

During the fourth quarter of 2022, Core’s net debt was reduced by $11,700,000, which also reduced the Company’s leverage ratio to 2.29 as of 31 December 2022, down from 2.42 at the end of third quarter of 2022. The Company will continue applying free cash towards reducing debt until the Company reaches its target leverage ratio (calculated as total net debt divided by trailing twelve months adjusted EBITDA) of 1.5 times or lower.

 

On 26 October 2022, Core’s Board of Supervisory Directors ("Board") announced a quarterly cash dividend of $0.01 per share of common stock, which was paid on 28 November 2022 to shareholders of record on 7 November 2022. Dutch withholding tax was deducted from the dividend at a rate of 15%.

 

On 1 February 2023, the Board approved a cash dividend of $0.01 per share of common stock payable on 6 March 2023 to shareholders of record on 13 February 2023. Dutch withholding tax will be deducted from the dividend at a rate of 15%.

 

Return On Invested Capital

 

The Board and the Company’s Executive Management continue to focus on strategies that maximize return on invested capital ("ROIC") and FCF, factors that have high correlation to total shareholder return. Core’s commitment to an asset-light business model and disciplined capital stewardship promotes capital efficiency and is designed to produce more predictable and superior long-term ROIC.

 

The Board has established an internal performance metric of demonstrating superior ROIC performance relative to the oilfield service companies listed as Core's Comp Group by Bloomberg, as the Company continues to believe superior ROIC will result in higher total return to shareholders. Bloomberg’s calculations using the latest comparable data available indicate Core Lab's ROIC improved to 7.2%.

 

Industry and Core Lab Outlook and Guidance

 

 

 

Looking forward into 2023, Core sees crude-oil macro fundamentals continuing to support a multi-year recovery cycle for the oil and gas industry. Crude-oil demand for 2023, as forecast by the International Energy Agency in January 2023, is projected to increase by 1.9 million barrels per day (“mbpd”) to a record 101.7 mbpd as consumption in China grows along with the reopening of its economy. As crude-oil demand is projected to exceed pre-COVID levels, crude-oil supply is projected to tighten. Production growth continues to face constraints due to prolonged underinvestment in many regions around the globe and the natural decline of production from existing fields. As a result, Core Lab expects operators to expand their upstream spending plans for 2023 by mid-teens compared to 2022. This supports Core's outlook for continued improvement in international onshore and offshore activity, with projects emerging and underway, most notably across the Middle East, Latin America and West Africa regions.

 

Turning to the U.S., Core sees similar challenges with crude-oil supply which should require increased spending by operators to grow and replace production. While operators remain focused on capital discipline, 2023 forecasts indicate their U.S. upstream spending will increase approximately 15% year-over-year.

 

As customary, Core expects typical sequential seasonal industry patterns will cause activity in the first quarter of 2023 to decline in some regions. As such, Core anticipates Reservoir Description first quarter 2023 revenue to be down low to mid-single digits, sequentially. Continued volatility with crude-oil trading patterns may impact Core’s Reservoir Description segment’s international growth within its Russian, Ukrainian and European operations. Production Enhancement segment revenue is estimated to be up mid-single digits as U.S. land activity is projected to recover from normal seasonal declines experienced at year-end.

 

Core projects first quarter 2023 revenue to range from $125,000,000 to $129,000,000 and operating income of $11,500,000 to $14,500,000, yielding operating margins of approximately 10%. EPS for the first quarter of 2023 is expected to be $0.14 to $0.19.

 

The Company’s first quarter 2023 guidance is based on projections for underlying operations and excludes gains and losses in foreign exchange. First quarter 2023 guidance also assumes an effective tax rate of 20%.

 

Earnings Call Scheduled

 

The Company has scheduled a conference call to discuss Core's fourth quarter 2022 earnings announcement. The call will begin at 7:30 a.m. CST / 2:30 p.m. CET on Thursday, 2 February 2023. To listen to the call, please go to Core's website at www.corelab.com.

 

Core Laboratories N.V. is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance. The Company has over 70 offices in more than 50 countries and is located in every major oil-producing province in the world. This release, as well as other statements we make, includes forward-looking statements regarding the future revenue, profitability, business strategies and developments, including the Redomestication of the Company made in reliance upon the safe harbor provisions of Federal securities law. The Company's outlook is subject to various important cautionary factors, including risks and

 

 

uncertainties related to the oil and natural gas industry, business and general economic conditions, including inflationary pressures, the ability to achieve the benefits of the Redomestication, international markets, international political climates, including the Russia-Ukraine geopolitical conflict, public health crises, such as the COVID-19 pandemic, and any related actions taken by businesses and governments, and other factors as more fully described in the Company's most recent Forms 10-K, 10-Q and 8-K filed with or furnished to the U.S. Securities and Exchange Commission. These important factors could cause the Company's actual results to differ materially from those described in these forward-looking statements. Such statements are based on current expectations of the Company's performance and are subject to a variety of factors, some of which are not under the control of the Company. Because the information herein is based solely on data currently available, and because it is subject to change as a result of changes in conditions over which the Company has no control or influence, such forward-looking statements should not be viewed as assurance regarding the Company's future performance.

 

The Company undertakes no obligation to publicly update or revise any forward-looking statement to reflect events or circumstances that may arise after the date of this press release, except as required by law.

 

Visit the Company's website at www.corelab.com. Connect with Core Lab on Facebook, LinkedIn and YouTube.

 

For more information, contact:

 

Gwen Gresham - SVP Corporate Development and Investor Relations, +1 713 328 6210

 

 

 

CORE LABORATORIES N.V. & SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

(Unaudited)

 

 

 

 

Quarter Ended

 

 

% Variance

 

 

 

December 31, 2022

 

 

September 30, 2022

 

 

December 31, 2021

 

 

vs. Q3-2022

 

vs. Q4-2021

 

REVENUE

 

$

127,571

 

 

$

125,966

 

 

$

125,139

 

 

1.3%

 

1.9%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

OPERATING EXPENSES:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Costs of services and product sales

 

 

99,816

 

 

 

98,930

 

 

 

96,987

 

 

0.9%

 

2.9%

 

General and administrative expense

 

 

8,724

 

 

 

10,001

 

 

 

10,927

 

 

(12.8)%

 

(20.2)%

 

Depreciation and amortization

 

 

4,073

 

 

 

4,171

 

 

 

4,398

 

 

(2.3)%

 

(7.4)%

 

Other (income) expense, net

 

 

(660

)

 

 

(1,781

)

 

 

(1,373

)

 

NM

 

NM

 

Total operating expenses

 

 

111,953

 

 

 

111,321

 

 

 

110,939

 

 

0.6%

 

0.9%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

OPERATING INCOME (LOSS)

 

 

15,618

 

 

 

14,645

 

 

 

14,200

 

 

6.6%

 

10.0%

 

Interest expense

 

 

3,081

 

 

 

3,138

 

 

 

2,590

 

 

(1.8)%

 

19.0%

 

Income (loss) from continuing operations
   before income taxes

 

 

12,537

 

 

 

11,507

 

 

 

11,610

 

 

9.0%

 

8.0%

 

Income tax expense (benefit)

 

 

5,847

 

 

 

3,856

 

 

 

8,823

 

 

51.6%

 

(33.7)%

 

Income (loss) from continuing operations

 

 

6,690

 

 

 

7,651

 

 

 

2,787

 

 

(12.6)%

 

140.0%

 

Net income (loss)

 

 

6,690

 

 

 

7,651

 

 

 

2,787

 

 

(12.6)%

 

140.0%

 

Net income (loss) attributable to non-
   controlling interest

 

 

(61

)

 

 

127

 

 

 

99

 

 

NM

 

NM

 

Net income (loss) attributable to Core
   Laboratories N.V.

 

$

6,751

 

 

$

7,524

 

 

$

2,688

 

 

(10.3)%

 

151.2%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings (loss) per share from continuing operations

 

$

0.14

 

 

$

0.16

 

 

$

0.06

 

 

(12.5)%

 

133.3%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings (loss) per share attributable to Core Laboratories N.V.

 

$

0.14

 

 

$

0.16

 

 

$

0.06

 

 

(12.5)%

 

133.3%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted weighted average common shares outstanding

 

 

46,826

 

 

 

47,012

 

 

 

46,927

 

 

(0.4)%

 

(0.2)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Effective tax rate

 

 

47

%

 

 

34

%

 

 

76

%

 

NM

 

NM

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SEGMENT INFORMATION:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reservoir Description

 

$

78,124

 

 

$

78,996

 

 

$

80,097

 

 

(1.1)%

 

(2.5)%

 

Production Enhancement

 

 

49,447

 

 

 

46,970

 

 

 

45,042

 

 

5.3%

 

9.8%

 

Total

 

$

127,571

 

 

$

125,966

 

 

$

125,139

 

 

1.3%

 

1.9%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating income (loss):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reservoir Description

 

$

6,817

 

 

$

9,798

 

 

$

7,216

 

 

(30.4)%

 

(5.5)%

 

Production Enhancement

 

 

7,904

 

 

 

4,417

 

 

 

6,993

 

 

78.9%

 

13.0%

 

Corporate and Other

 

 

897

 

 

 

430

 

 

 

(9

)

 

NM

 

NM

 

Total

 

$

15,618

 

 

$

14,645

 

 

$

14,200

 

 

6.6%

 

10.0%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

"NM" means not meaningful

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CORE LABORATORIES N.V. & SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

(Unaudited)

 

 

 

Year Ended December 31,

 

 

% Variance

 

 

 

2022

 

 

2021

 

 

 

 

REVENUE

 

$

489,735

 

 

$

470,252

 

 

4.1%

 

 

 

 

 

 

 

 

 

 

 

OPERATING EXPENSES:

 

 

 

 

 

 

 

 

 

Costs of services and product sales

 

 

393,655

 

 

 

367,896

 

 

7.0%

 

General and administrative expense

 

 

38,117

 

 

 

44,173

 

 

(13.7)%

 

Depreciation and amortization

 

 

17,161

 

 

 

18,516

 

 

(7.3)%

 

Other (income) expense, net

 

 

(722

)

 

 

(5,595

)

 

NM

 

Total operating expenses

 

 

448,211

 

 

 

424,990

 

 

5.5%

 

 

 

 

 

 

 

 

 

 

 

OPERATING INCOME (LOSS)

 

 

41,524

 

 

 

45,262

 

 

(8.3)%

 

Interest expense

 

 

11,570

 

 

 

9,152

 

 

26.4%

 

Income (loss) from continuing operations before income taxes

 

 

29,954

 

 

 

36,110

 

 

(17.0)%

 

Income tax expense (benefit)

 

 

10,296

 

 

 

15,891

 

 

(35.2)%

 

Income (loss) from continuing operations

 

 

19,658

 

 

 

20,219

 

 

(2.8)%

 

Net income (loss)

 

 

19,658

 

 

 

20,219

 

 

(2.8)%

 

Net income (loss) attributable to non-controlling interest

 

 

205

 

 

 

492

 

 

NM

 

Net income (loss) attributable to Core Laboratories N.V.

 

$

19,453

 

 

$

19,727

 

 

(1.4)%

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings (loss) per share from continuing operations

 

$

0.42

 

 

$

0.43

 

 

(2.3)%

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings (loss) per share attributable to Core Laboratories N.V.

 

$

0.42

 

 

$

0.42

 

 

—%

 

 

 

 

 

 

 

 

 

 

 

Diluted weighted average common shares outstanding

 

 

46,813

 

 

 

46,690

 

 

0.3%

 

 

 

 

 

 

 

 

 

 

 

Effective tax rate

 

 

34

%

 

 

44

%

 

NM

 

 

 

 

 

 

 

 

 

 

 

SEGMENT INFORMATION:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue:

 

 

 

 

 

 

 

 

 

Reservoir Description

 

$

307,691

 

 

$

313,609

 

 

(1.9)%

 

Production Enhancement

 

 

182,044

 

 

 

156,643

 

 

16.2%

 

Total

 

$

489,735

 

 

$

470,252

 

 

4.1%

 

 

 

 

 

 

 

 

 

 

 

Operating income (loss):

 

 

 

 

 

 

 

 

 

Reservoir Description

 

$

22,902

 

 

$

28,958

 

 

(20.9)%

 

Production Enhancement

 

 

16,351

 

 

 

15,163

 

 

7.8%

 

Corporate and Other

 

 

2,271

 

 

 

1,141

 

 

99.0%

 

Total

 

$

41,524

 

 

$

45,262

 

 

(8.3)%

 

 

 

 

 

 

 

 

 

 

 

"NM" means not meaningful

 

 

 

 

 

 

 

 

 

 

 

 

 

CORE LABORATORIES N.V. & SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands)

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

% Variance

 

ASSETS:

 

December 31, 2022

 

 

September 30, 2022

 

 

December 31, 2021

 

 

vs. Q3-2022

 

vs. Q4-2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

15,428

 

 

$

13,732

 

 

$

17,703

 

 

12.4%

 

(12.9)%

 

Accounts receivable, net

 

 

106,913

 

 

 

100,195

 

 

 

96,830

 

 

6.7%

 

10.4%

 

Inventories

 

 

60,445

 

 

 

54,795

 

 

 

45,443

 

 

10.3%

 

33.0%

 

Other current assets

 

 

28,916

 

 

 

26,493

 

 

 

29,079

 

 

9.1%

 

(0.6)%

 

Total current assets

 

 

211,702

 

 

 

195,215

 

 

 

189,055

 

 

8.4%

 

12.0%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Property, plant and equipment, net

 

 

105,028

 

 

 

107,252

 

 

 

110,952

 

 

(2.1)%

 

(5.3)%

 

Right of use assets

 

 

52,379

 

 

 

56,589

 

 

 

61,387

 

 

(7.4)%

 

(14.7)%

 

Intangibles, goodwill and other long-term assets, net

 

 

209,245

 

 

 

211,134

 

 

 

219,459

 

 

(0.9)%

 

(4.7)%

 

Total assets

 

$

578,354

 

 

$

570,190

 

 

$

580,853

 

 

1.4%

 

(0.4)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND EQUITY:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable

 

$

45,847

 

 

$

34,343

 

 

$

29,726

 

 

33.5%

 

54.2%

 

Operating lease liabilities

 

 

11,699

 

 

 

11,472

 

 

 

12,342

 

 

2.0%

 

(5.2)%

 

Other current liabilities

 

 

45,589

 

 

 

41,544

 

 

 

48,714

 

 

9.7%

 

(6.4)%

 

Total current liabilities

 

 

103,135

 

 

 

87,359

 

 

 

90,782

 

 

18.1%

 

13.6%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Long-term debt, net

 

 

172,386

 

 

 

182,677

 

 

 

188,636

 

 

(5.6)%

 

(8.6)%

 

Long-term operating lease liabilities

 

 

38,305

 

 

 

41,975

 

 

 

49,286

 

 

(8.7)%

 

(22.3)%

 

Other long-term liabilities

 

 

75,574

 

 

 

74,886

 

 

 

91,148

 

 

0.9%

 

(17.1)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total equity

 

 

188,954

 

 

 

183,293

 

 

 

161,001

 

 

3.1%

 

17.4%

 

Total liabilities and equity

 

$

578,354

 

 

$

570,190

 

 

$

580,853

 

 

1.4%

 

(0.4)%

 

 

 

 

 

 

CORE LABORATORIES N.V. & SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

 

 

Year Ended December 31,

 

 

 

2022

 

 

2021

 

CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

 

 

 

Income (loss) from continuing operations

 

$

19,658

 

 

$

20,219

 

Income (loss) from discontinued operations, net of income taxes

 

 

—

 

 

 

—

 

Net income (loss)

 

 

19,658

 

 

 

20,219

 

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

 

 

 

 

 

 

Stock-based compensation

 

 

7,756

 

 

 

19,093

 

Depreciation and amortization

 

 

17,161

 

 

 

18,516

 

Deferred income taxes

 

 

433

 

 

 

6,012

 

Gain on sale of business

 

 

—

 

 

 

(1,012

)

Accounts receivable

 

 

(10,078

)

 

 

(13,522

)

Inventories

 

 

(14,860

)

 

 

(4,547

)

Accounts payable

 

 

15,374

 

 

 

6,568

 

Other adjustments to net income (loss)

 

 

(10,488

)

 

 

(14,748

)

Net cash provided by operating activities

 

 

24,956

 

 

 

36,579

 

 

 

 

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

 

 

 

Capital expenditures

 

 

(10,216

)

 

 

(13,539

)

Proceeds from insurance recovery

 

 

583

 

 

 

726

 

Other investing activities

 

 

5,777

 

 

 

2,590

 

Net cash used in investing activities

 

 

(3,856

)

 

 

(10,223

)

 

 

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

 

 

 

Repayment of long-term debt

 

 

(131,000

)

 

 

(226,000

)

Proceeds from long-term debt

 

 

116,000

 

 

 

155,000

 

Proceeds from issuance of common shares

 

 

—

 

 

 

60,000

 

Transaction costs on equity distribution program

 

 

(411

)

 

 

(861

)

Dividends paid

 

 

(1,853

)

 

 

(1,834

)

Repurchase of common shares

 

 

(3,903

)

 

 

(8,256

)

Other financing activities

 

 

(2,208

)

 

 

(508

)

Net cash used in financing activities

 

 

(23,375

)

 

 

(22,459

)

 

 

 

 

 

 

 

NET CHANGE IN CASH AND CASH EQUIVALENTS

 

 

(2,275

)

 

 

3,897

 

CASH AND CASH EQUIVALENTS, beginning of year

 

 

17,703

 

 

 

13,806

 

CASH AND CASH EQUIVALENTS, end of year

 

$

15,428

 

 

$

17,703

 

 

 

 

Non-GAAP Information

 

Management believes that the exclusion of certain income and expenses enables it to evaluate more effectively the Company's operations period-over-period and to identify operating trends that could otherwise be masked by the excluded Items. For this reason, management uses certain non-GAAP measures that exclude these Items and believes that this presentation provides a clearer comparison with the results reported in prior periods. The non-GAAP financial measures should be considered in addition to, and not as a substitute for, the financial results prepared in accordance with GAAP, as more fully discussed in the Company's financial statements and filings with the Securities and Exchange Commission.

 

Reconciliation of Operating Income (Loss), Income (Loss) from Continuing Operations and Diluted Earnings (Loss) Per Share from Continuing Operations

(In thousands, except per share data)

(Unaudited)

 

 

Operating Income (Loss)

 

 

 

Quarter Ended

 

 

 

December 31, 2022

 

 

September 30, 2022

 

 

December 31, 2021

 

GAAP reported

 

$

15,618

 

 

$

14,645

 

 

$

14,200

 

Stock compensation (1)

 

 

(1,868

)

 

 

—

 

 

 

—

 

Redomestication costs

 

 

246

 

 

 

—

 

 

 

—

 

Foreign exchange losses (gains)

 

 

691

 

 

 

(1,303

)

 

 

(32

)

Excluding specific items

 

$

14,687

 

 

$

13,342

 

 

$

14,168

 

 

 

 

 

 

 

Income (Loss) from Continuing Operations

 

 

 

Quarter Ended

 

 

 

December 31, 2022

 

 

September 30, 2022

 

 

December 31, 2021

 

GAAP reported

 

$

6,690

 

 

$

7,651

 

 

$

2,787

 

Stock compensation (1)

 

 

(1,494

)

 

 

—

 

 

 

—

 

Redomestication costs

 

 

197

 

 

 

—

 

 

 

—

 

Foreign exchange losses (gains)

 

 

552

 

 

 

(1,043

)

 

 

(26

)

Debt issuance costs write off (3)

 

 

—

 

 

 

171

 

 

 

—

 

Impact of higher (lower) tax rate (4)

 

 

3,341

 

 

 

1,553

 

 

 

6,501

 

Excluding specific items

 

$

9,286

 

 

$

8,332

 

 

$

9,262

 

 

 

 

 

 

Diluted Earnings (Loss) Per Share from Continuing Operations

 

 

 

Quarter Ended

 

 

Year ended

 

 

 

December 31, 2022

 

 

September 30, 2022

 

 

December 31, 2021

 

 

December 31, 2022

 

GAAP reported

 

$

0.14

 

 

$

0.16

 

 

$

0.06

 

 

$

0.42

 

Stock compensation (1), (2)

 

 

(0.03

)

 

 

—

 

 

 

—

 

 

 

(0.01

)

Severance and other charges

 

 

—

 

 

 

—

 

 

 

—

 

 

 

0.06

 

Bad debt

 

 

—

 

 

 

—

 

 

 

—

 

 

 

0.01

 

Foreign exchange losses (gains)

 

 

0.02

 

 

 

(0.01

)

 

 

—

 

 

 

0.01

 

Impact of higher (lower) tax rate (4)

 

 

0.07

 

 

 

0.03

 

 

 

0.14

 

 

 

0.08

 

Excluding specific items

 

$

0.20

 

 

$

0.18

 

 

$

0.20

 

 

$

0.57

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Quarter ended December 31, 2022 includes non-cash adjustment of stock compensation expense associated with certain performance
      share awards that vested during the quarter.

 

(2) The year ended December 31, 2022 includes non-cash adjustment of stock compensation expense for shares that were granted but did
      not vest. The period also includes stock compensation expense recognized pursuant to FASB ASC 718 "Stock Compensation"
      associated with employees reaching eligible retirement age, which is nondeductible or partially deductible for tax purposes.

 

(3) Quarter ended September 30, 2022 includes debt issuance costs written off upon renewal of the credit facility.

 

(4) Includes adjustments to reflect tax expense at a normalized rate of 20%.

 

 

 

 

Segment Information

(In thousands)

(Unaudited)

 

 

 

Operating Income (Loss) from Continuing Operations

 

 

 

Quarter Ended December 31, 2022

 

 

 

Reservoir Description

 

 

Production Enhancement

 

 

Corporate and Other

 

GAAP reported

 

$

6,817

 

 

$

7,904

 

 

$

897

 

Stock compensation (1)

 

 

(1,250

)

 

 

(618

)

 

 

—

 

Redomestication costs

 

 

156

 

 

 

90

 

 

 

—

 

Foreign exchange losses (gains)

 

 

321

 

 

 

309

 

 

 

61

 

Excluding specific items

 

$

6,044

 

 

$

7,685

 

 

$

958

 

 

 

 

 

 

 

 

 

 

 

(1) Quarter ended December 31, 2022 includes non-cash adjustment of stock compensation expense associated with certain performance
      share awards that vested during the quarter.

 

 

 

Return on Invested Capital

 

Return on Invested Capital ("ROIC") is presented based on management's belief that this non-GAAP measure is useful information to investors and management when comparing profitability and the efficiency with which capital has been employed over time relative to other companies. The Board has established an internal performance metric of demonstrating superior ROIC performance relative to the oilfield service companies listed as Core's Comp Group by Bloomberg. ROIC is not a measure of financial performance under GAAP and should not be considered as an alternative to net income.

 

ROIC of 7.2% is defined by Bloomberg as Net Operating Profit After Tax ("NOPAT") of $26.8 million divided by Average Total Invested Capital ("Average TIC") of $372.9 million where NOPAT is defined as GAAP net income before non-controlling interest plus the sum of income tax expense, interest expense, and pension expense less pension service cost and tax effect on income before interest and tax expense. Average TIC is defined as the average of beginning and ending periods' GAAP stockholders' equity plus the sum of net long-term debt, lease liabilities, allowance for credit losses, net of deferred taxes, and income taxes payable.

 

Free Cash Flow

 

Core uses the non-GAAP measure of free cash flow to evaluate its cash flows and results of operations. Free cash flow is an important measurement because it represents the cash from operations, in excess of capital expenditures, available to operate the business and fund non-discretionary obligations. Free cash flow is not a measure of operating performance under GAAP and should not be considered in isolation nor construed as an alternative consideration to operating income, net income, earnings per share, or cash flows from operating, investing, or financing activities, each as determined in accordance with GAAP. Free cash flow should not be considered a measure of liquidity. Moreover, since free cash flow is not a measure determined in accordance with GAAP and thus is susceptible to varying interpretations and calculations, free cash flow as presented may not be comparable to similarly titled measures presented by other companies.

 

 

 

 

Computation of Free Cash Flow

(In thousands)

(Unaudited)

 

 

Quarter Ended

 

 

Year Ended

 

 

 

December 31, 2022

 

 

December 31, 2022

 

Net cash provided by operating activities

 

$

13,211

 

 

$

24,956

 

Capital expenditures

 

 

(2,021

)

 

 

(10,216

)

Free cash flow

 

$

11,190

 

 

$

14,740

 

 

 

 

 

###

 

 

 GRAPHIC 3 img77179564_0.jpg GRAPHIC begin 644 img77179564_0.jpg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clb-20230201_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Address, City or Town Entity Address, City or Town Soliciting Material Soliciting Material Amendment Flag Amendment Flag Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code City Area Code City Area Code Document Period End Date Document Period End Date Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity File Number Entity File Number Entity Address, Address Line One Entity Address, Address Line One Entity Tax Identification Number Entity Tax Identification Number Entity Emerging Growth Company Entity Emerging Growth Company Country Region Country Region Entity Registrant Name Entity Registrant Name Pre-commencement Tender Offer Pre-commencement Tender Offer Title of 12(b) Security Document Type Document Type Written Communications Written Communications Security Exchange Name Entity Address, Country Entity Address, Country Entity Central Index Key Entity Central Index Key Local Phone Number Local Phone Number Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Cover [Abstract] Trading Symbol Trading Symbol EX-101.PRE 5 clb-20230201_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.SCH 6 clb-20230201.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 100000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink XML 7 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Document And Entity Information
Feb. 01, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Feb. 01, 2023
Entity Registrant Name CORE LABORATORIES N.V.
Entity Tax Identification Number 00-0000000
Entity Central Index Key 0001000229
Entity Emerging Growth Company false
Entity File Number 001-14273
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Address, Address Line One Van Heuven Goedhartlaan 7 B
Entity Address, City or Town Amstelveen
Entity Address, Country NL
Country Region 31
City Area Code 20
Local Phone Number 420-3191
Entity Incorporation, State or Country Code P7
Entity Address, Postal Zip Code 1181 LE
Title of 12(b) Security Common Stock (Par Value EUR 0.02)
Trading Symbol CLB
Security Exchange Name NYSE
XML 8 clb-20230201_htm.xml IDEA: XBRL DOCUMENT 0001000229 2023-02-01 2023-02-01 0001000229 false 00-0000000 8-K 2023-02-01 CORE LABORATORIES N.V. P7 001-14273 Van Heuven Goedhartlaan 7 B 1181 LE Amstelveen NL 31 20 420-3191 false false false false Common Stock (Par Value EUR 0.02) CLB NYSE false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 1 23 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document And Entity Information Sheet http://corelab.com/20230201/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports [EFM.6.05.45.cover-page-fact-not-visible] Submission type 8-K has 1 cover page fact(s) in ix:hidden that should be visible or referenced by an -sec-ix-hidden style property: EntityTaxIdentificationNumber - clb-20230201.htm 8 - clb-20230201.htm 8 clb-20230201.htm clb-20230201.xsd clb-20230201_lab.xml clb-20230201_pre.xml clb-ex99_1.htm http://xbrl.sec.gov/dei/2022 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "clb-20230201.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 23 }, "contextCount": 1, "dts": { "inline": { "local": [ "clb-20230201.htm" ] }, "labelLink": { "local": [ "clb-20230201_lab.xml" ] }, "presentationLink": { "local": [ "clb-20230201_pre.xml" ] }, "schema": { "local": [ "clb-20230201.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "clb", "nsuri": "http://corelab.com/20230201", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "clb-20230201.htm", "contextRef": "C_36994fd9-30d1-4d47-9be0-bf0c860ca642", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document And Entity Information", "menuCat": "Cover", "order": "1", "role": "http://corelab.com/20230201/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "clb-20230201.htm", "contextRef": "C_36994fd9-30d1-4d47-9be0-bf0c860ca642", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com/20230201/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com/20230201/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region", "terseLabel": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com/20230201/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com/20230201/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com/20230201/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com/20230201/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com/20230201/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com/20230201/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com/20230201/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com/20230201/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com/20230201/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com/20230201/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com/20230201/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com/20230201/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com/20230201/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com/20230201/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com/20230201/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com/20230201/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com/20230201/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com/20230201/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com/20230201/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com/20230201/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com/20230201/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 16 0000950170-23-001616-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-23-001616-xbrl.zip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

&V [ M427@WE*KW@?A4>!]DOU+TZ..K>+JCSR(EGC8;MK!=*+O9[8#;U]2N:F)#'4& M9KQ)IL)V!!?+:V-TLXX6(9]#28!OE17,[5Y]^[)H-)21:1,_%B[CARF0K<)+ M0XGMN=&"LMC4GDF1V*ZPIC=AN5$2(?&X[3FG%SH#EN+U20^DYP0.62HT(E)M M68=#. 0\DR7$=\\#+[68^\/X2$&N_'E![%UVMR3._.:1*+EG&R+MYA&Q7^T- MD*"I0$K3"89,IZED#C(7ALAI4XF4)$L,E[.F'8_86F M-#",W4N2&A(-#%^+^5D#HH'QZF%NV,!H8+SZIIRTX=/ Z/58XMM@:6 4>YAF M-S!^<.S*?FX.>YG]+80/#8Q1[7]4,$!^<'BZLRHNO0,4&!I_NSK9%N@7_=^5 M5_\!4$L#!!0 ( !>(059P0:0JTW8 *0P$0 . 8VQB+65X.3E?,2YH M=&WLO6MWVTB2+?KYGE^1QUVND=>!. 3XEKMF+5FB7;S'EER27#W]Z2Z02%+H M @$V'K(TO_YF)@"2>EFR39$1P)ZS3I=DD7C$SAT[,B(R\^^7Z3SXK_\E_GXI M74_]5_P]]=- _M?PO_<'@X;]]__,?U4?^,_B$W\?1]Z-2-*;0/[V:N[&,S\\ M$&Z61O_;GR^B.'7#].W"]3P_G!V(_N+Z[2MSV47YE51>I_M^Z,DP/6@VFJ_? M3J,PW4_\_Y$'MOI]D;[-+[J?1HN#_!_,)Z;NW ]N#B[\N4S$B?PJSJ*Y&Y8? M'D=I&LV+SYM;N($_"P]B?W:9JD?XN[Y&^0AC=_+7+(ZRT-N?1$$4'\2SL;O7 MM,S_>_/VWK_9;]Y^O?13N9\LW(D\6,1R_VOL+O+G^BKU+0[&4>#=?Y7U)__U MWUF4OCV,?3?(?[1$XH;)?B)C?_IVKE[BJ^^EEP=3/U6/%:;*0.K!A]>7_MA/ M18Z&OMY__?T_%[LT:2"G]RSZN'F^;8T[MU[:Y9LF^?5O=K?YEI8Q_/E,)/'D MMU?JAU[/[@TZW?;_UVS\:S%[)=P@??#?2]N95[2;/<65RWPPV:V.(.X&+P:%V.G_%4.@' \D!D)M$2OY^(@!G$YGX[[TQPSPQ(-NWN7O^#&W M/J!>S,#.9I_[!4?LAI^4#[EVZI2[SW'*+Q;\F?MZ+:Y].SBW/Q_O3+V<7OXH\OAV<7PS-Q>'(LWG_Y M^%'\7(Q.OHQ./HC3S\.SPXO1Z#>'$P#>7T?K']E2>I/;\IW,)_:3U(W M3M\:2/:5)>?)P=A-I/%2#P6X*VO8C5[+?KT+1._'+X]A^@.2=+NFZ-A9N/Q9G%MTA MS=GPS^')EZ$X?2]^L9V^^#3Z^%'QXJWX\EF% JBM&1T0[&WY2OZB?\R^= MJR\=#=6L3%VFWWQMB>.SD9(X\>Z?XO/9Z?&7(QWVB>')[X'G\7P/Y[GE!891'R(*_5<,HP#UP! M5\ 519/AL"#,Q]-_Y"RQP1*P!"Q98\G)\$(<#]]=B+.AFI\,C_5<1?.D5_+D M5K) @#5@31U9F M$J2X=/IIJ/YZ9$(T<7$J+GX?BB^-\P8(! *!0$?#<_&'K>NDK5*)E+@SF.,S>^,0"\ M$?OB*(JE^.B.=?-*%/O:.HT_&V+OY)_GPP/QZ]]:[;='']^9_[X1>_GOZBOF M!TLL?]>7*/XMBD5Z*%-\/9:Z3UQZ8AIE<7HI_JV>))5Q7C2/Y94, M,RFBJ2X)]JQN4YFNV6R(_':**?;@;2*BA=1M-N%,^.$DFDOQU4UTI:/\O"6^ M^NK2GA]D^D[2C4/UX42HKXGDTE5/FK_$\/-Y\53ZACKS9 DW"-15A3N91+'G MAA.97TL[;S&3H;IQ$-SH/\N%OK;^7!::9UG$ZFG\1:#,EU]>Y[7RZS>$N%#F MF/JANJ)"3KUHD@5IHHR0&^J.,=3C&'NH"P:9)X4KPBCK&WN)>BPW%5^3:8A4/;!)[JY>> MJZ?+8O6Y'*ZVU2L?_<:7@5XSL(9LSLI$OZ3MO%97##V=(UR_20Z:HX:'.!33 M+-!F54-^X@=^_L[J X\_1B+\I#2PIR'7;^>FJ3NYU*-S^?'4'2M(&R_8D;GY M!JO==D,_XC&?6B:P*3-06B%0"?%X'^7NV;KCAM>]=;L_*.FL2:4=D6)1^[68 MQM'<4$NY1W6=&^6,%5]O7TAS=U__97E)[2%<[TK&*D:]$;X2D(GV0^,;BD5L6/UCH%Q>7Z81KDO]Z(@<.-$ M/<2:'!/TFU,YS$49+V,>Q5-C\$K=2MG0RR:I2)7TZ N4)M&?*?^6N%IE]0/E#Z@? M1B$EDR07Q5Q6M.7UJ-J/E WWBY&G=5BIU=B\5F[38@PI<9QD<2S#R8V8!NHV M^0A+S)UG,EI$@0)NHB1AJKX4Q0^.T%LH*J3NC EG-29N/YDB8C8VP\\W 48T MG28R+=15F]0\B[JW22R??(6UXD][__D7 ([&B,Z(G4GHC>ZL_+N'R6A3N3^V,5?/RU[T[5LQZX MP5?W)B&X"GGW5H-;_'%"EM/W-2?UR R^2.$IIZ2_[:NHP--.2ODB%37.(SV/ MS^8JXDK$5Q7B3"Y]J6.@1/X[DR84T)%%K*($,^%7;K0(+:Q[.1#K@;GSR7WHN8\AE7QO%0>5V&F6*Q4.TPN]4V-[51<:GY1<;?^S'*JX.:3#FV661 I MR]R>401Y//"MFXX55]+_?QC13BL'CI9 MR$EJIB7Y5*>:Q(E>NB&ZMG,H#V3GG+LB0Y;#;W5<-?T^1+ZVBF?Z]@[(0T@ MQC+3^.8T%&UQHG5@+-=S?[K"HX9F&&D_[!EY523RDV)T7A7#6MU8_;L>V.8C MIJR0W!G@AW.EC;'GSJVE# :N^D*92?+,PF7NSUQ39\T<1:G) MZKE-://H!4K%,=12-Y;E)37<_XSBOQ3+="5E6&8!C9\PGTANYN,H6,Y\37TL M#W]0*OAIME"S%AS,QDL*@9H]E',G;RF"138_IZ>EV6CWQ/_KALMR]8-^2,VP M0A,-QC**9VZH'O61O',4+[3D2QW,ZPROKD;FD[E\)F6^%M_1W>*A%NJ9PM14 M5?5$9EG8.)$Z$:L>P4L>E&BQEY?"3&*C!7 M!E(3OZ(H:V+H.\_XU5<3#QE>KNJXEU&@?96NE"BW=E6XK4!- ?>5X]6/'IN( M/%$A?Z &5 G&@S;*IP5K%5HS>;HWF5E.FEQ/(>^;R96>Z$ZB)$V*-[SSY.K: MTSQ+?K6J;116^(]D_542*W_+PA4_"/"_U(0\\?SE3*H8#KF-OH68@4I_0P5D MN@ N>7AQ^''X\5U:])T,Y53[J<)'WG5+17_%@=CSWP@W]P_%'^XXFVD4I;J# M)BT]TKL51NV<2+F?)BD]S=N)EG_.\J[6,*%<4E M=!:C*)WI5B3CU,8*DC)7L>>K9RWR(-Y]'Q'UOQ3O\0VE26/3;W)C MY5DS-3+Y%L+R M\5+SQ:7'IET.Y#7&_SZ._^LA,:AN>N),JF]<17ZLRVR3V#<5?](CBMB0@=!L MVJ(/#LFU%+-P34XZ,MT8BC>Q#%8JH1/WGO'5MWLI;B6TEYGL0$7:05(436[W M;_2;K[72E?T=293%>OYA DOUN7^9#'04^PJ.O!(396GB>WFP:MJ*'GZ/\H*% MFCQ22S)MD[V^92\[/J.OH4@";7KU<.OE$O-J]WI?/JS7P971HYF M%;/%N?Z$3@X%9<^R?OOXRI^L%/D;-KS?MF.M]]N48-SMM+D]=LJ^FWMML$_U M]"JXW7S)^]A-_"1'M5NV!9G262 ?*.^M^EZ+;S2?USW;?\UB*D/:5U(S%N1E M*_)2>H)IT0!+MBWUX3^34(NU M>$3Z?K8I]><-FE;>EPG_A1:M%S4;6K0JY]'3K]&W^K2?X3$?Z-ZV5T%7E=NU MB4&)<&?3%CU^>FZWJG1[?BPGJ_ZR MOI*.R\J&-]-Y5W:J*=;.8GQ!F*OT>IM!$1G MRV_U N-P/]9MHG[XKV* S=Q$EG7"$F1/ZG*E6:YC>B672W;&@0R]8A@G$B@3 M1]E@FR?5XJ7X3H/,]Y)R;=>5[Q4HYZD1PV_O*G<5\M_YU&H_FNZ;NA5+J-))OH!6/3+!!3G4#18A^4 M=2N338R+3)F:EZSJWZML5M%=:UJ'\\R+CC7F2A]TI48Y)3>449:HZ&"N+C1S MB]4JRI=-)KJX57K49''I!LI497D_SW7E244,:JJ#>C6T\B*=Z7C7-;Y0J*&@ M_)$:7WK0F_9ZP$@?QE4"/Y;30/V@?$3>R:X8+*]57.,MPWN9F.YX%:<8[(_< M>*PN<.0N=.W5_-.Y<@:N[E*YW<;_#YWX6>AL=ZROFN>+RC*%FH5&RG#)>EJ[ M6 5KE<^)<(;V8-(+96Z\.)J8(;$_EGEW@IXM9K&:CYIDXKRH66EG<4ZRE((NLYY=MB0=U$FH*L6>IU)S(O/$_Y M;['NA4_PRC6O5BR[/[26XJL M!?)W[N3%OID?*$>K9HT*X,2ZM1;1U#/4-%)'^/_._,E?N0,.\FZL-15V0S>X MR2<#ZD'32"%N.D>G;I+NI[$:'LL=G?0[E;J^9KI%E!8+.O63J]C!3)+VJ<>WJJ\G-M"^&CQF$5ZBFV;3*)3YRDG7TDL=BQV5 MUN]QN^@?NBHPTME09?#$_+S<0R1ON#9"IUY+C["BZZWU9CGU7\Z5;K]U_MQK MCVQ";C/.M"HLV_J\ MPCBW+)_W$JLGNV]S=OYP:\6:IF,9!-SPF M^29:YE<%H9EYFG\Q6V!=^8F&JFAY_EQ\?%^O.)O+_8O5YV^%IGJ%IEX4<9)J8C1.&M=XW4SYVW;^3M$@4>2SAOLU ]J0P6RF"YKS"?\9-UUBYI M6J3M:.LG%K75H /R\VH]=I&KUF0F#0;&)=-X[>&Q=FOY?+Z=@DY*KFUWH%4L MD-?%?Y>"FBF1"J]TL*'+,BK@T8^?2^$]3ZU;2F[M6[#^U55"I%C;;V0UB,9* M:I1\/FPUV#W;0]58;83ZS@Z[W M[/TGNZ_S#2#6=N6XOXG&^O5O;4=F-YNOO[WUV[K*>[X["R.]@F+5TCB+%2&, MT1SG(:OU[EF--#V)\0\ST!V4EUWC>_;'9IO(%>O*Q94JXM:1:U$-"F7>':;' MM_$ 13+4M&NO[?Z5>S45?R=ND.9S3[W_3I3H:9?R<(EI+5-3MK4NY_+ORYC6 M]'.[DV)VX2>WZD#IK5U\BQA6?_>VU]6NUO2&ZSNN6DU,P2K?4V:MIJE7=*IW M6Z3^7"]<726DUY<>6<)NB_^)=)%(/[)N9_%*O^P*LW6.F.HY:ZIW*#9O.];3 M/&VZW'AC6>SU:V8O=]..>CM(8]_]8E,;;SG5,$U\_JR8M)4;\>CB_G(VZ@JE M2FH\J^=7EU93C7R]I6F$UA8L(#*#0L\ZRIFTFGO/S6YMIM_/^.KTMCO\G 5J MPO$/]TJY2[O3>BLNLG&F.R"/M+GUODKG^436S%SN?OOWX=G.\Z7*Z"^1,57F MZ*VVLN'K*\3O>H&S20?IW;5G*I"9:-;< S[3Y6-7$1S@[%_D*I>^#/RV4=2Z>DA[BB<:R,KZ\8YU<9R_2K[K$-M(._63?[!.YU-+60GRETY?Z14Q%:E515W'#NYMB M7V%]\7M!Q.J9\TI0L8MAXNH*F)EAM_02SW)S@L3D[_4*G&QNCH$P4_MR&I_O M.)-/&4J:%,V+8 )+)B1%E.;=BW8D;3#'2ELVQFJ]/EAM5%-Z > M(#+1!XCHI5_Y$K'$^-#5)"]?P)4G^'1:RHLR4Y'4C%)C3\W3?#W=,=/7,M6G M+I!W-M^:K )0\G#LZ[1#Z)$&!^.9TGA^ 8N:--BM/8M-<49'#W/W6B?SM -^?_3^ MV\=AY4WK.HF6%/MJZ\::M9TM IUBG+@+39G\&"]%#'V 5;$M]+?2K ]>,#]^ MJV4YQ0)<3:F'KJ]$1SW>+\X#.PVHM\I/6K'+J]P_U&>Y47B^:UNTVFISK&<3 MZA9A/IM8[A%:[/.VW)KNP9V5\JVAXO)=]5:CA3M8+V2-I=E3MZB6I5%^IMER M?[K5-GAZ>V\((QP)[7+);6HM]\W73"YG(+?WT%_6C/5LJ_S(@WP*\FX[F7=* MF47X#6>@.:3NWK)O;Z=;[#EC/(K3:#NBV(Y2FIUT=+9?Q=1WGO[.SI:WO8%> M='.3;W]=NHM[9#6OJ@]9#&YU[\4Z'-=S07U8@:L#^+OOLJ>F0V:I3>Y=TTA[ MN*7Q1[UP0NWX>O2O_80YF"-/+I#AK47UD^&YT<7QHCHFT&QTST=/[_"@W MHEPD$K9P<7!Q3VXH[G3%Z22-;F\HOG)#^4:WBF#G.G%QY2>Z[_;8+#W6R^KR M$U7-AXHC6U?;_[IKL8#Q(,N (#\AM&FOG?QJ\CGSN2FWJ+G_^M1[X?JFL<;I MW][[7/O$6_%)WK8;Q>;3O=L?UF=39:F^HI]>ZB\8M^)>YY-[62R&7FY%NXI= M]'JCN-B$UNZ\1DP"PNZ6L'<.BLX3ICE-E_LUN]]-.,6R&]-SK_ZA*SZYL:** M.0C\FR2S6[AB+*O#-+1UUB#==69FPT*1;A061VX?Y1-RTH 0\UE0 M@4U;]&+E\<-'IH_#_- U-6GZM-K(>CW9LTR*K8Y:RZL;19*LS 4)LRMX,?K+ M=%0>]IV=CHZ649^7I]3*O9W,IDIGRK9^'D-_L7K9*2Y2? MFH=/HW+95+IO]E858UUMT5DXT\"7;V/J)Q-_D1^.7#ZL>G(S<[WT%[K .8_T MX0_+Q%I9OBS.=DA,+6A6I,"*UL.\\*E UD<8&)4TQ7D=$?MFNEEFK;1%:.L6 ML9$,W_!RON%2S6R694ZS.7VY"5I0U"+G9MNFN4QC?Z*C+D_.]:Z618UR.;[U MJ+[UC9S*5[)LO8W\(-^KI6B-+_J%M4O1)\CD:9[\6%_CJ<0'9MW'DD$U06V[+HSH/\),SZ$"V7C;?J[W=M@M-A\YG)FYE0K/;A\7 MZ"?E.M:BV2 L#A]7%[,; S'7>P^HR>+8U1/'Q"0N]=FCR\U(Y^.%M]J-5$\. MR[RDW;0;/:'_7BR=3;+YHCS=ZNC2#UVS_6]R=V^%6$:+XA#QJ:E>JLN%T?PF M/^QB'EBR^J:&1*_JNO--LQ18ZLGOVIKC8H?B MVXTLKHFM38CNA^:@>UE,4_6KZ/Y#'5;DT_7RK/!Y7I2=%<>QF(WNETN&EPF$ MOR2&3347SW#)!E5*%[5;= M/3G]]C;0#QZA7IXX8Y6[V13+K=4U8K-6+C_Q7!E:Z8 EYKH=.8ST/.MF?4GV M)]_S%,6&BB&6LHMZG')W7G.!?^C)Q>'4_,YB]VG,$Y@*RX6:"!>:L-I<8"4I M92OSVH)=,^[ON:V\(JLXHD^L*):=+/VVM^*R(N\MZFM/5NQ8I6B>;RI5.);E M#K&K+\3*N_KAK0T5BE3=*K=GY5ZB%*!D-17/_8LYDN.^DS'Y@J70W-Y$WN[P M6JP/-C)EHPXES*)L-RXW9"\%,[U9Y$> K3:T2-10-4I51F6K([SRABTW2];. M2"L/V?)C)2ZW^[U:^0*Q7-W5YY+(+!XK3LO24JZWZ2J>2!^@H+AFCDE^^$B& MV[\J#YVWXB-H=EF='[B^UTEF=/ MJ3^IWU=G4>4'_-[=;RAO=.^L?Z==_OK4YD%WU-]L!33\?+XZ)?!!%^HGA;-> MDO>79L-NFWNK'P:@%"CU0C6]>Q7^!Y@U*W+X>IP66_@L]T\WTW\]NO/*P\T: M,TQB0.^/>FU.!4_R[?'-/P61WC)3F( \5J\9+H^XTZM12>ED@:2]CQ,#D[\M-AT92 M#K=\"Z*IC,U&VA,]%/6,S4_4='&9XWQH9T=9#M^R]5Y/.(K5/>8R1?/M3.^1 MD(K>04L%5(UY0QR=7XC_%([^?6%^'UYHP;BXS.+$TZE-YUYW[T64=W2$939) MW\ 2B\"D5&9FG5+QJ%_E./'USDJI^/KU:T.16P;N6/V7^$;"Q,8+J6IM)1A8 M%BKR7>1UD]))X\^&CIER\LK;EN;>69B@. MS2J3 ?)6,J#8.73M,[KEJ-A&L=QJ<"'3. ID-E_?2G[5?M40=WV(R0'TFKJ$ M49ZU;CH64W5KT=%'^69A:MZT*%P%T:0XX%A(4PZ M24_-&O4.KK>.@B[M.'<]\Z9ZLPX3P6:+8K^9Q)U*O:V-&C"Y3=,9X4_,.;)^L8_8RE?YX33OI]6^K-ROMCCDI3QD0W=L M3"Y-5Z\Y65)=>:H3WX5;ON.MK3O)>@7:7S+W\>O_O(B"8E/@26!R>_=5P.3T M]_.,OHI89;3V'15^JWEBJN0F&ZL?Q*5T U."\!-]I?5S3$R+Q[X]$+JM02I3 MY&>9Y+T6Q=+V(NF2*@T,=56T-&4A5C,MVV&A52;#:01T>3IVDHNX/C[DIH@P MQKEFWSX)Q#0@Z/-JU.A\KX90(NSF_O^U]/_^8:[;W_^_8NH'Y7EV2L:FNB1L MFL+7BL+B?"5CILY19'KTK8HSM(RT)7)-M,JGG9BJ<%Z.NOUXZ@/9VE$Y9DXS MG:[M6*?>KE@-&"7RWHLF\AM1@WIFC1'>8E/WG^9@9%]?STSOQ18&=NVK1 M,4L^S;^:"'%%W3Q^S-\DO1-:AM'J56)#[$S/3PLR?".>*_H$M%7&4ESY\FN^ M#&!U7/3MB&^%1Q'[K4>\B'DPJ87"/S>M9+R05AU#WTA)V6RY\BY7-N5'LH5G MDO"Z)U1-::21KD?YG!>;\_-7]9PL-?NL3/QXDLW5A\+):O6@ MI]!,,M9"47HV%!\/WYV>'5Z\W^,GQ\.1\>"S43^>G'T?'AQ?JE_,+]9]/PY.+R.=THTR/M$UW M+UR0^Q^Q6KX15O$XQ2OHZ/; S=+H[3B*/1F;!_3#V4'SK?GX?N#>1%FJ+G\M MO;?YK>RF,6'Q!46AP%TD\B"1>MN=5);6,5;(KVW04 ^PA$VW9.1EQ8/R^\6' MU*>\I^1#:@XSL)_^S%.?L!O]3OOG+U/)AW& MIMGH]9^\CMWL/.,Z@]9W7TC]$-\=KI>YX\_]_/UQ^K#(.)V.5?Y_+2N*+KFG M.LC]E?Z'A\7FS@E4N9O1S_B8/RL=QYH:[7@*O"E)O.?('L02 .P* &5N]0CA M;Z_LYJOMHE'(S])D'168)E'@>^)V./> &7>$XLZF89L:"W\43>Q#93&/!B>? M& 7KMU-X,!@.-&C]/1@6$.3AWN,\A/M]2??;6GG?'([\Q1\#@Q2P\.1;]^2O MQ9]N[*_O'OFH"_C&<+KO78DZ_>>.E%J4CS#3X>CI 0 5J74PT:FZ/"Z/ZFO9 M9NMR-'SP E>EY_7O4H:XH_6/N-0%JSEX5U![MV0N[W/.)A"[0NUKQ]&BU7[ M_-GPS^')ER$-GM+"D9^F/@U &+$Q_P_0:"N,^84&5QX,&'8$WX-K-UBY0=OI M69W>ML(51BQD[N\@.! <" X$AZ#@=*Q!MPL60G @.#4=ZA <",Y6!<=N#7\W6-UFL:L()7//P?Z+=1^@V8T:^^=5SBP, O H#J MMWT##+ ! N".R8 %!O ."."($! !@!@"0^#YPJGT6L(23@! _?!>JP MI4Y]D^=8!%6-15#%(3@G'\3POS_K(W/.#WA1L$[JA7DH(3 "H-P!P1X3 M H-X P!T1 @, , ( 67H>."'56#U(P D>O@O484L=9.DWD:5?MW#'7&BC M !8&-P<,=U;F1B;_NW0T]L8@C+YNH-W(#F?"B+10/ M2Y"I6QKK^+?HX08#JV]CWYB:<8B6K2$7&.J0"QYRT;<&K28X5"\.T;(UY )# M'7+!0RZZUJ#? X=8<0B5RZJH"O/R"RM7UV2W2Q%XA>IG9>CGL*,?*JBHH%:_ M@OI!AC)V U,W=3WU*3])8S?UKZ20UPL9)I(7:R&:F)Y1MS12'%MT<'VKY[1! MH7I1B):MH188ZE +%FIAJR=HXES FG&(EJTA%QCJD LNXW\=W4C\*\ ME#J/E-'_Q_P#+\)",C$_HVYIY#BVZ-O:5K/7 H7J12%:MH9:8*A#+9BHA=U# M_;1F%*)E:Z@%ACK4@HE:M 9]4(@5A5 ^K8JHH'BSS>)-H\6M=@-FH7I:'0+V M&FUN!$3Q%,73ZA=/3]-+&8L]/YQ$<_FF7'9JB5"FO.@*O7R1N5DAMTL;/::W MM&!BCL@3E'@N)DB7;#2&Z79)[.WX!/KK-U,HD*/F#V"^%7C?T. V+; @=Y"[ MG5,";)0=6KT^BF S!@^!!\"!X$#P(WLL*7HM&KRT$C[#@H0)?%5U$ 7![ MSO7D$PU0P2H>W@_DJS'Y4'E'Y;WZE?>+*'4#$2VDWO$YG)6E=YR96PFA1%J& M'R)(RQ!TD[9M6X,.\C)@)P0+@@5*0+ 8"%;+0>4<[(1@0;! "0@6><%J6H/6 M@ $I(5@,2C>T(*FBKJ%VMLV3B[O,UJV"5RA=5XA^.+F82_&:.##PBP!@:P H MH9C*DGZ[L M,>,?2J(HB?(.[T?:;<@D+7>XY,4_Z!^V7^$Q(\/V*RS=8\MJXIPM8F+5M#KB!7.Z<$Y&H7>!MH_^&634,S$(UNC($M >H1J,:S=]=LB+=*)Q$5T(*T8C.#Q$THA-TE1VKWR:1-DO(0R(I'"8[*&1 I+M]FUNM@O M#=R$7$&N0 G(%76YZEG=#@Y/ #K4_/TE*]:=R+3<33JO5?,B(!00FU51 MMS0V?*MC 1D4@EI +3#4H1:$U8),_184@EI +3#4H1:$U8),^104(E<*H 5) M%44%M1A40T$MPBX0#$0UE #N5=#URW<,1?:*("%P;5AB\OOWJ>R8N:]BJEP MTS3VQUGJC@,ITDB$4;C_\/&]^BIQ% 1Z#;"O?91,4EX>8?Z#T"^%7317@2U@]I![:!VQ33?(5%08*YVU68F+5M#K"!6.Z<$ MQ&HG)XP.&/ 16L6@5$0+DBI*&FIU6ZP(?*(!*EC%P_N!?#4F'XKD6#+,>QKP M= '\*(JE>+@"_M%57M9-H]C7-FO\V>#%7DCG%N9T3L/1VNM%F1Y/E+,L5,ML MO]!@U?-A1:)FLXN@>S26M3TY )"M@>I!]:!Z4#VHWL_"W[,Z3IL%KZ%Z4#VH M'E0/J@?5^UGX':O;[[/@-52/06V*%B15%$<4![>YCKW9:&$=>S6HA?(\0P;: M';OA,"-@?4OTQ(&!9P0 6P- F5L]0OC;*^<5P-@U& -0; +@C0F !0 M;P#@C@B! 0 8 8!,/@^<*I]'K"$DX 0/WP7JL*5.?9/G6-^VU?5MXRCP7H!S MQWZ0I=(3THU#/YPEY1JWA50 7[JQ%-,XF@O]!3_,]$:ND?J3F_I1F/!B*D0. M_8T_Q]&M5)#1W_@30//O;VPV;#3U5[Z]$:)''@"('D0/HKNRH#5$#Z(' MT8/H0?0@>C\O>DV(7N5%#^7OJF@C\QH>*]^H#V3M8"%;-:B%*CI#!MJM5J/% MC(#UK<43!P:>$0"@5;N.8 %!O ."."($! ! O0& .R($!@!@! R^3QP MJGP>L8:0@!,\?!>HPY8Z]4V>8R%;/1:R/7AL&PYHJZ3@H=41K8YH=:323(!% M;75H=83HD0< H@?1@^AM3?30WP_1@^CM&@"('D0/HK.%4^CUA#2, )'KX+U&%+G?HFS[&H;:N+VEZL9%4N M:\OOHWYPE8G=F51SGOD\"O.E;8F(LC1)W=#SPQDOAD+!4^7SB#6$!)S@X;M M';;4J6_R'$O JK$$;#B=RDGJ7TF1NMB_K$%L[4A.1!\B!YD#Q(7CTDKX=-/"!Y5(I"M#"M MHC(RK\JQI" $SQ\%ZC#ECKU M39ZCP[T*'>YG\DJ&F417.UG!PM23$!@ #4&P"X(T)@ 4&\ X(X(@0$ M& & Q#P/G)!=K!XDX 0/WP7JL*4.$O-(S&\E,?]B)R6<2?7WJ\B/Q;%,)K&_ M2/THY$5"Z->+G,I%R_Q4C]CZA097'A1Q'(OWH\?B]2W;(7$:+"T2,G=WT!OH M#?0&>D-1;P8#$D>QTB(A0&^@-^3TIJ^>8- #"5GI#4JI59$EYO4@ M5JYNSV[8;UX#V&H6^E"BY4A)I]&A0DD4>E'HK4>A]W,<>=E$5W?%,+QTPXF< MJS_P8B%"SA>9A!4JNK318S)*"R;FB#Q!B>=B@L3()D= >V"UVR02(T_@OWXS MA0/(";V"7D&OH%@U&7 2>@6]@EY!K\A0 GJU$[U2WK_M,. D](I! M5886)%64-93%MN<;.XT6D:(8=5CY,0UU:H:$'#3Z1 B)*O4VJ]3K%NZ8"VT4 MP,+@VK#%Y7@>] ]Z!YT[^=UKV,-NB367T/WH'O0/>@>= ^Z MMQ7=LUL#%LR&[C$H/]&"I(KRB/K?%MTC"O(HR%<<.6:$'! A) KR3Q7DB0.# M" 0 5/_X*.KJ0P,>0%)O2."RX++ #T#""!*X++@L\ .05"]A!L\&ZE2,.H"$ M'"1(_W-%#JE[5FOI*A8/O$2Y;!P%W@MP[G0A8S?UPYGPPTDTEV(OB)+DS0$O M%M8IS-O9!!9@@ T # '9$% P @'H# '=$" P P @ I.YYX(1L(R !)%2\ M&9 C1R:D[I&Z)Y6Z?[&5+F=2_?TJ\F-Q+)-)["_TN6V\2(@HKP8'9F-C YQ: MOS6GV+7Z-HFSV6AQD+FW@]Q ;B WD!MRH,^. BY@=S4=*A#;B W6Y.; MGN78)+8@I<5!TMX.E=6JJ!+S8A K3[?7:C;:;XCLY$0=67YD0X&6(R<[C0X5 M2J+,BS)O/E&(EJVA%ACJ4 L6:M&VVFCJJ1N%:-D::H&A#K5@H19=:S!H@4*L*(0B:55$ M!069+691^F0.NZ&.*S^JH43*D)%VJ]$DPDA42%$AK4>%]"B*%U'LIE*XH2=. MTTL9\Z(@HLTMG!?\N(32@HDY(M]UC/?CF" ELLD1T!^02)\_ ?[ZS9HXOAMB M!;&"6$&LZB96[5:3 2$A5A KB!7$B@PE(%8[61,S8,!'ZEI%=0W]&U:%'%J8 M5E$344G;GF,]^0104=BN,G*@(ZK:Q*O:ZQ;NF MM%,#"X-JPQ>5W'[>P8N5% ME+H!+V(B^MS"#-!I.%I6O2@;!Y)T3H;JU(_(]FG/AQ5IG8WV\76LKDUB8\\G M1P#UY YSKPO9@^Q!]B![]9"]MM5M=U@0&[('V8/L0?8@>Y"]#TR38= ;9 MXUEYH@5)%=5Q\[U0*!'^[ #H-KI$EKY6!7Y^S-V6AZT*PJP(KJO9/!C^XU%2 M??L&D$E@Z7$!P L H,RM'B'\[97S"MV&]. !)/6&!"X++@O\ "2,(('+@LL" M/P )(TC@L@ (&V.362KL90N_Z9^P ,_5<\^^0;^K?;;DT_F/V(N MU25$&*7F)S^<33,LO"/K(S&SQ#0&D)"%!"X++@O\ "2,(('+@LL"/P )(TC@ ML@ ('__=-O[,IRU>UN.9T$3T(0P3=1_W7$@S8^/F>EUW:RT0V/\ MT QG"^:X7!9#%^Y,YH3<=Z?J60_'%Z=GH^&Y.&G\V1"_NO/%6W'^Y=WYZ'ATJ/^] M[@9_; Q_O\%/CH7)R+T_?B]/-0X3%2 M'ZB;V5_NC)%1*-++*%,?]1)+R.N)7*1B(96[O71C*3PW==_ VINR]I?0S3QU M=X^T37<5I6M#F'"P?)#U3;S=+(W*M=GZT?QP=M!\:SZ^'[@W49:JRU]+%9N; M6]E-8[WB"VH8!.XBD0>)7+CZ..?2,/EN N;:K^ZV75WYB3_V S^].2B__T#W M57Z[CMWH-^W7VI(/336*9VJTVLZ3GVD^]0FG,6CV?OXRFWJ8_J"_G8=I-9I. MY[LOA(8ZS,P!P',!6":JNEO.4V'7E6<'W9L:"O^4;BR&RER>.)83.1^KJ*]E M6S3(^=V[L% ?X_3T88DN[W>.40Y"_[&, D (3?GSK?ORU^--57PDG\F>& MTWV/2M31HZ""=4,5\>X 8-?3G&VWET(>MRZ/3M-Q:# 1%/FWM2F MP41XTYU[4V2(@!-6ZE0B7D&V!-D2'KNL/(;VV?#/XY*PK6N;' MT73/C1IPX-Q/@]KN#ZQ>B\1!J[18R-S?07 @.! <" X]P>DU%3+;*K$P8B%I M?X?4'0]=0NJ.HTMLV$0.,T3Z#V<35M(O H J%?(!!M@ W!%9, (P P MNP=.G&;W_)##S!R-.:P*/+O+AA7;-IU\$,/__JPW>3H_X$7!.JD78FY"8 M %!O ."."($! !@!@!0 <$(*H!(N#BF 3:0 UBW<,1?:*(#K>Y5V5N9&FN#9 M6T!'29J(:*H'SI4_4>_NAIY8Q)&73=0;N8%,>-$6BH/%)&_Q_S#[P("\E$$$G=TIB(;=&WV3W+ M[F[KQ")PB B':-D:>@BTJ8,??#))QH*C)0I4J;4-')WK+R(4C<0T4+JM3+)61('!GX1 ."(P#J" 0 0+T!@#LB! 8 M8 0 9O? B=/LGA]RF)FSZB:JF*=CE0T[_3P\.[P8G7P0HY.CTT]#L??Q]/P< M*TTJH6#8FH..I;&]S3;KI+;5<=K@4+TX1,O6D L,=<@%#[E0P'1)K)P'A\BE M9VA!PD]5D$9CZ!'W^M@-#HL6)/Q4#6E(AA[4Z3;:R$(B M"\G=7;(BW<@U&RQ1ZU^HT'"0ED91D[S!9T>ZY?82\> EEQ(2/1TR)"1]+MVD/K&ZGSX"3 MF/!!KZ!7T"LRE(!>[:1GOFDY]H !)Z%7#!)?M"#A)VM(4#)TH7M.HX_\)/*3 M[/TE*]:=R+1I.PZD2",11J'Y?!P% M@6X=](MC4G@Q%5*)1@P>028:,5@Z4J?984!(=&% K"!6$"LRE(!8[>3(Y0%. M1JDX,Y&KY*%IR%4R])\GGVBH)_*4R%,B3YGG*8_T:2@?7>5/W32*?6V=QI\- M7CR%2&XASG0:CE99+\KTR*$\]?L!AFZ%C+_08-7S8<7L<<.MCNU.BP6Q,86$ M[$'V('N0/!F2OY_18$!NRQR C1PL2?NJ(S"E#)[IG-]KH\N22/24.##PC M -@: ,K^#$:7[/#SG,S-'7 MQ*I\]&0^;!P%W@MP[M@/LE1Z0KIQZ(>SI.QM6D@%\*4;2QS<4'&10XD7)5Z4 M>*E4)YJ--L&%,2CP,@U/(7H0/8@>1(^\Z*&9M_*BAZPG#VU$UI.A"]US&BUT M-7')G1('!IX1 *"-H(Y@ 4&\ X(X(@0$ & & ^3UPXC2_YX<<9N;H:F)5 M/*+;U82]F^HC>"CVHMB+8B^52@4ZG.I0[(7HD0< H@?1@^A!]"!ZW#)KM"#A MIXW(@#)TH;_^[=IIVNVW:')BDDHE#@R<(P! 5T$=P0 *#> , =$0(# # " M %-\X,1IBL\/.3$JGZTNY18V>:4WT?]X"H3NS.IXKOY/ KS5J=$1%F: MI&[H^>&,%T,A;JCMA;KAM.IG*3^E12I>RUB-Y6\& CQ0MV5 M2UD'=5>F3K+59L%)ZC57JMNT,"L'0?(@>9 \2-[+MAI!\B!Y5#)DM##EIXS( M9#+TP">?:"@PWY M(8>9.;J46&6F=W6PV_GPPZ?AR848G;P_/?MT>#$Z/3G@Q< ZB1=";D)@ M4&\ X(X(@0$ & & # !P0@:@$BZNOAD XL# IP$ A,)U! , (!Z P!W1 @, M , ( ,S,@1-FYI5P]/]"95'^_BOQ8',MD$ON+U(]"7B2$?KW( MGDVTS$]U Z9?:' %FZ9M=)_09L_J#FRP\"Z*S/T=! >" \&!X- 3'+ME=9L# ML)"5X""1QT.7D,ACZ!+W[,;@#;,=W9$.1#J0=R#R.8Z\;*)S@&(87KKA1,[5 M'WBQ$#*XA3W<'Y=16C Q1^2[3E5X'!/,UC8Y NR^8S4I'JQP;P"LWZQ)\%B% M:K.3EJTA6!"LG5,"@K43P>ITK6Z[Q8"4$"P&>2Y:D/#3->0C.?K0;L-!.K*& MZ1&E;L"+F!!&G/SZ' M&3[69Y)J=GJA3=I/%S)V4S^<"3^<1',I]H(H2=Y@TW:R H9=D@F! 0 0+T! M@#LB! 8 8 0 L@# "5F 2K@X9 &0!>#=H8A-VRNK7Y7:O1,-WMA#=VM.T7&L M09-$US8M$C)W=] ;Z WT!GI#3V_ZUJ#3!PE9Z0W2>#QD"6D\AAYQSVEBSW9D M RO@,%G1#GNV5U<'$1G2L31F5UO=;M%J=7 "8\TX1,O6D L,=<@%#[E0H'1) M;' .#I%+\M""A)^J(!G'T"/V&GUDXI")X^XM67'N*(H74>RF4KBA)T[32QGS MHB 4$"=1\8@=<1(52P_I6$Z/1%8/YU 1YB8M6T.N(%<[IP3D:B=I1<@:YB'7+8QC$^D1$\"W"M MOXNS(?]T='HV%!\/WYV>'5ZGIP/CX7ZZ?STX^CX\$+]\N[PX^')T5"<_SX<7M3.V"_7;3D* M17H99>JC7E):=>^(RMG_J;GQ@T.H.?O\JFGF70[Q-Y%CTD[?9@[?]^_I+/,$"OV=[) M55!&1LX& *"(PA , Z@T W!$A, *@W '!'A, (P P&X2!+Q6:^6U M#$J-;P6?[KJ*^%$/ND"OC&<[F_"0V(C_1_?&Z@6 M/1E(G^Y^%IL63^I#@@:SMXHA((&SA;-='PKG. $K\O/ZUXE#?%':Q_!+?PM:G0UH7M[GW%XA;(;MI]'] 0 MB"<0 ;8 -P163 "H-P!P1X3 ", $!)@@=. U!L >"H>.&%+ M6:Q'J=9ZE!?;B>W(32Z%&ZKYB_Y!_COSK]Q _2GA141XPA\%((S8F/\'B+45 M#OU"@RL/UM9W!-^#NQ2ST-.;EM5K;:MO ME!$)F;L[Z WT!GH#O:&G-SVKUVR!A*ST!@6(JL@2\R7-O%R=TVB_IH$KB,7# M 8)_FSSM1Q%P\(89 U':16F7=X1_.)FH)TT3$#\*K]0/4>Q++'&MA/1ADD7'TDA4;#-Z;UKM-O+:->,0+5M#+C#4(1G6=[ MR0J_H P"]HH8(](JB7G6M]H!$ MRAYZ19B[9P2T*N=Z-7 :O8&##@)O6)0DJ$%215E#36Q+>Y"T+"9 ME<3 *Y2D*T._O6:CBQV+ZUB37K=PQUQHHP 6!M>&+2Z_>Y_*BID74>H&J%M7 M4"C1)DS'TFBUWV8>Q+:M7A-G_]6,1+1L#;W 4(=>L- +>Z"0L;&4MV8DHF5K MZ 6&.O2"AU[T!U:S [W@12+43:LB*RC<;,_7]=EMJ0I>H6Y:&?K9#I;RLBF; M$@<&CA$ ; T 96[U".%OKYQ7 &/78 %!O ."."($! ! O0& .R($!@!@ M! "R^#QPJGP:L8:0@!,\?!>HPY8Z]4V>;W+-4<4\':N*U>@I9+ :M68DHF5KZ 6&.O2"AU[836L O6!&(M0EJR(KS(LKK'S=GM.P MN6T+!V:ANED= G8:+6X$1(T4-5+>(?Z9OKR(IB)+)+9E#+FK&(5JVAEQ@J$,N6,A%U[9:_1XX MQ(I#J(A61550D-EB0:;7:',KR(!9J(A6AX!VN]'CQD"41%$2Y1WBC\+4#6?^ M.)"))691Y'WU@\ L'HW22QF+( IG^\JWS(MZ*5:25D8F?W)*]MRSYFG!Q!R1 M)RCQ7$R0)MGD"'": \MIDSB7XHD!L'XS!038"<&"8$&P(%@U$RS;MNQ6FP$I M(5@0+ @6!(L,)2!8NQ&L@=7ND&A<@F#Q+]S0@J2*NH;*V18K9\W&@%OA#,Q" MZ;HZ!$3ENJ:5ZW4+=\R%-@I@87!MV.+RN_>IK)AY$:5N@)6^%1+(C<[>G(:C M%=:+LG$@22=5?H!U6R'8+S18]7Q8D9?9Z'JR7M]J=0@6$AX8 LC,0/>@>] ] MZ!YT[^=U3SW H,F"V= ]Z!YT#[H'W8/N_;3N]9M6O]-BP6SH'H,Z%"U(JBB/ M* 1N\0B!1IM9&1"\0AV^,O3;:_+;PZ&^=7CBP, S H"M :#,K1XA_.V5\PI@ M[!H, Z@T W!$A, *@W '!'A, (P 0!J?!TZ5SR/6$!)P@H?O G78 M4J>^R?--+F*KF*=[B9+5. J\%^#"X.3X[%\(\OHXM_'O B M89WT"S-10F !0;P#@C@B! 0 0+T!@#LB! 8 8 0 \O0\<$*RL7J0@!,\ M?!>HPY8Z]."$#6#U(P D>O@O484N=^B;/T>2^U2;W%]N7Z7 R44^:)F+AWKCC0/+B M'Z3K1?;OI&5^[+?[W/ !N^C^-*CMCM5O]T#"NR R=W?0&^@-] 9Z0TYO6FVK MU2:Q:3LM$C)W=] ;Z WT!GI#3F^<@=5SNB A*[U!%;4JLL2\%,3*U;5:C0ZS M$P= +)1B*\._3KOA,.,?ZKFHY_*.[T\7,G93/YR)0+J)%('OCOW 3WV9\*(B MI!"S+NJ61N9BFP?XV59W, "'ZL4A6K:&7&"H0RZXR$6[YX!#]>(0+5M#+C#4 M(1<\Y,*Q6FW(!2\.H2Y:%55!76:++2"-)K.R#'B%LFAEZ+?7:3AOF!$0=5'4 M17G']Z?II8S%)(MC]3NJHE53PI^<=B@CS(AM>_ M=OHDJJQ/X+]^,X4#R F]@EY!KZ!7-=,KV^JTVPPX";V"7D&OH%=D* &]VHE> M]:V>#;VJ.#E1F*Z*K*$RMCW?.&CTF-7%P"L4IBM#O[UNHXW"=!T+T^L6[I@+ M;13 PN#:L,7E=^]363'S(DK= ,7KJJHE&H;I6!I-]]MLNF^V++O5 8GJ12): MMH9>8*A#+UCH1;]GM3HDFI/ (<@%Y )#'7)!6"X&3:O7QYI>7AQ"Z;0JJH+: MS18S*?V&S:QT V*A=EH=_K4:76;\JV_IE#@P<(P 8&L *'.K1PA_>^6\ AB[ M!@, (!Z P!W1 @, Z@T W!$A, (P"0QN>!4^73B#6$!)S@X;M ';;4 MJ6_R?)/KCBKFZ5A5K#Y&X6Q?D7XN/#E.+1'*E!<%H5YH5:)N:;3[;;,&WW.L M5K\+$M6+1+1L#;W 4(=>\-"+OF-U>SV0J%XDHF5KZ 6&.O2"B5[TK6X+\PM> M)$(ALBJRPKR:PLK7[74:76Y[P8%9*&=6AX!]?@1$411%4=XA_JHH&BUD[*9^ M.!.!=!.)31>KIHJ8@=&Q--(86_1QK;[5:F+/Q9IQB):M(1<8ZI +%G+1MJU! M#W)1,P[1LC7D D,=AVKTVN#0_7B M$"U;0RXPU"$7/.2B;?61ZZX;AVC9&G*!H0ZY8"$7 ]NRVWUPB!6'4!JMBJJ@ M,K,]5]=L#)B59< K%$8K0[\]N]>P41CE4A@E#@Q<(P# B2MU! , (!Z P!W M1 @, Z@T W!$A, (P"0Q^>!4^43B36$!)S@X;M ';;4J6_R'*N*JK&J MZ")*W4#(?V=^>L.+>Y"M%VE2*E1O::/'9(\63,P1>8(2S\4$C8.;/GABT"&Q M+NF) ;!^,P4$V G!@F!!L"!8=1.LEN4,6@Q("<&"8$&P(%AD* '!VHE@=6VK MV;09D!*"Q:"00@N2*NH:\TH6*^?8:MC,EI* 5R@D5X9^=J_19L8_5*,W48U> MMW#'7&BC !8&UX8M+K][E\J*F'G%>FWW2^&&'BK8%=++C4[EG(:C!=>+LG$@ M26=8?H"%6R'<+S18]7Q8D:39)/R=7M]J42R#/S $D*:![D'WH'O0/>C>S^N> M>H!!DP6SH7O0/>@>= ^Z!]W[:=WK-ZU^AV 7&72/9UF*%B15E,?--S>A?OC3 M]4,RY4.>_8;\>+HM?PHZ[V)OUV:C365KUQ?K5:QG X'ZKZLB2O/C8V9Z_;)6 M^J&-%QZUTT_[P!U:@I(4\#+#"].F,NS8G#DNEWU'"W^[T[5LQZXP5?W M)LE;D'9EM@=3$;NW&JE!]!(QR#@*O/5W<3;DGXY.SX;BX^&[T[/#B].ST?!< MG#3^;(A?W?GBK3C_\NY\=#PZU/]>&GS]14F]B:C[D-B4_B_PO-QL8A2*]C#+U M42]Y [-NRJQ?0C?SU-V]NS8U$?I#+;1NED;EA$@_LA_.#IIOS9#(A1N[J2QMG,_AS;5?W>TQOO(3W[2>WAR4 MWW^@U3B_7==I.,W6:PW*0]/%XID:G4'OR<\TG_I$IV'W?_XJFWJ6MO/T:]^^ M#'87(ST90GV=% #++:F[6]Z2&MG'9X=YFQH*_Y1N+(;*7)XXEA,Y'\M8M&R+ M!CF_.QE)?6#LG-\00D9^& !0$<)MG\T (=RZ$#I-QZ'!1*@>?V\*2.!?X5_O M^-=M;<8$_XI9!<6@EE6^?%79$>_/3C^)T\_#L\.+TA9-H+L5>$"7)&S&- MH[G0?_3#S ]G(EK(V$W]*$Q 6H*DW?;:5%KFQUKRYZ9ZL4+\IT&U!U:WTP<) M6:WVAMZ0!X#14(?>0&^VIC=.TW+L 4BX2[W!G!ASXF).[/E),2V6WMJLV!*A M3$4T%7[^E=2]EI@J(W3AN@$)4\]#[U]9DL[5+XE((Q%+]:>)'TA3%KXU)]5_UO\X M<9-+L8BC*U]O;32^*8O)X4RXD]2_,J<[8_TBV9 $"X8(@0$ $"] 8 [(@0& M *CV^L5B ^L7"\'M-5,C!G_NF#A/H\E?^V,WD=H=SA6,T!B?/+Z\LA3$'K.@4]ENI^ M$]],.X4;>L*=1\KJ_X-Y*"(+BN9G;FE$%MN,+'J6W=W6#MG@$!$.T;(UY )# M'7+!0R[Z5L=&WA(344Q$=S(1G&E:;$9 @H $ 0D+C[9GJT?H84=1WA$)! >" \&!X+ 0 MG);5<3 %YBTXF +7=0H\"J_4#U'LHWD8D0@Y\S.W-"*1K48B;:O?;8)$K",1 M" X$!X(#P>$@.&VKT^Z!0ZSU!C/?NLY\E\7?A7N#RB^B$8+F9VYI1"/;W(VC M8[5Z;7"H7ARB96O(!88ZY(*%7'2M3A=M0E@^BZGG#LAWFE[*6+BW3Y2\=XXD M#;=+BY^UBS#&ZM,R7MFHLU"VB +?$[<',RV8F"/R!"6>BPDBEDVW-K?[)&*6 M)P; ^LT4$.38R2I!#\6#XD'QH'BU5+RVU6M#\6JF>-O("W1>-BW0J7!68!P% MW@L,A1,U_9^XR:58Q-&5[TE/C&]$M)"QF_KA3+B3U+_R4[1I(TA"D(0@"4%2 M.0*'Y M[^+]Q]-_G(OW9Z>?Q.CDS^'YQ>CD@S@\NAC].;H8#<\/P$:";(0V40,# " M>@, =T0(# !0O5 9W5;$PVEWX:=N(.3U0H:>GV8Q6JM($A0+4AE;&FNZM[Q" MRK%)]$+1(A&K]F\(#@0'@@/!82$X+:O3(M',1(M$K 0',^!ZSH _Q]%$2B\1 MTSB:"S],LM@-)U(?AA@I\]_0\-BTB(W@!,$)@A,6[JW3;X% ]2(0+5M#*S#4 MH14LM*+G(&M*9H$-YJ#UF8/F.V'ZX95,L,T%(@HL&R: ")8-$W24':O7(W'6 M%%8-$^8F+5M#KB!7.Z<$Y&HGNS)9G0&)HW@A5YB#5V,._M+[3F:)]-1,')-Q M1#>(;L@@@NB&8'2SU[+ZV'.R;GUR$#P('@0/@E='P=,KBQP2_510O-UTAD," M*RJ! ";9W & P @'H# '=$" P 4+V]?"J&$ZNIY]UM+]^/3@Y/CK#M)7TV M0INH@0$ $"] 8 [(@0& *A>J(QF+]KA])E>BNYZ%^DF3F&(9H*B;1?!Z%(KET<3@A0@QZYF=N:8086_1RO_[MVFG: M;;"H9BRB96L(!H8Z!(.%8'2;F)+NFD.8DM9S2GH1J\_H[1_5[',2)6DBU _R MWYF?W@C/3]+8'V?FCXLXFL7NG(;_I<53A!JU<9,(-7B[N[VV;8-!K)NXH#90 M&Z@-U(:#VO2[4!O>:H-Y<3WGQ#>=,B\:(0Q"'( YAXM-7P) X/)86AUCI#:;!]9P& MGZ:7,A93/W3#B1_.A.Z1OO)3'[-@1"4X,9AD]((3@W>S-Z;E-/L,.+E^LR8. M#,8T'(('P:.-" 2/HN!U('=UDSMD 4AG <91X+W 4#B1J9BXR:7($ND)/T0Z M -$1HB,RB" ZHA@=.2VKU>LP("4").0#H'A0/$:(0/%(*IYCM3L#!J2$XKU0 M2@ 26%$)! #?#8 RMWJ$\+=7SBN L6LP J#< <$>$P NP/@I4I8%<.) MU=3S9'@ACGX_//DP%*,3<71X_KLX/#G.?QC^\67TY^''X0&^@-] ;!GK3LOJ#'BBT2PIALEJ]R>JCTU-+ MC*5Z\U#W5493<2/=F(9;I05V[2((M)C0BS308K*34]M[5H_&SD7,.TRJ34Y: MMH9>0:]V3@GHU4[T2DVAFR1V/H)>8IAM(WIYQ%,Z#4>[2B_* MQH$D';]0K8+]0H-5SX<5(=!&0Z".U78([A/QP A $ 39@^Q!]B![D+VJ9JHA M>\^:^ZO_NLI YL?'3/%ZS1)VDX(JV?=OFEOESJV7IOH^*^W0&"N/1,LN!&WQU;Y(\6;0KLSWH1W=O-5*#Z,7VX3)W]N0DBMW4C\(# M=0<9!WXHU]_2V9!+.XG"_0^'AY_%*)QJ3=-WI&'U#4;7[$?@O[(D]:_B+$,?'FE+)!>NJGZ'RGD]23($C7XS*%I*B!Q_5#XX22: M2^&&GOK[0H:)^H8,M< FPE??BX2\HG/_+V(Q7U[.<_FQNHB^D#R[69RT^',Y'&Y@QS\YB3* L\ M$>E][;_ZB50O(>9N\I?TQ/AF]0Z>^GV4RGG2$.^C6/V[GPCEW9,HM-3'EQ;( M]+N4[QF6))RK#V9Q:9?B>OK:ZG;FHN91[UI/W4%!F:C+FE=4OT3Z\'7U83$) MI!O+6!]#MW!C7SV%^.JGE^9QU5>R(-5/MXCB--^@;Z'L$1/\,J[G^>91TL@RCQQ&J7#U R796 WE-%.0*7]C MF0=97;A\)/4ZZG&+:TV4)_34!V3^Z/I9+'TQ _DT"Q38GI],LJ389/ V\JN+ M)\H\QOBY%:>^\JFS9&6/;&?.*9DGDU.@,_9Z[R?:=+WS/*O=_>QRA)WEBW?Q73.)JKD:G\ M59CI#Y^N')P>O,=^D&E*#]TX-*.\^-IGY0O.]5F4W[A W;!]N757(^V,HDQ] MU$LL[?0CZQX<-!\:SZ^'[@W49:J>UQ+[VU^/[MI@"B^H-X^)/$BT5BEI*6UL M)D_YM5_=[0>X\A-_K.B>WAR4WW^@+2"_7;O5Z ^QND/OO,RZ 2I;:T$ /SX#C-V<\M;S#Q@GAVAL[-( M=F/'O3T\$6A5_QTCUCN5$SL=*]EJV)9RFX]"@955& @U" M4X*.>C,A#<3@@NOC@L_E(BU\E7+GE8:?*6%YLY95^]M8+'P%%LQ;W,7A:Y-8A<%6B1D[NZ@-] ; MZ WTAI[>M*UN&T?-0&^@-W4=ZM ;Z,TV]<9I-D'"7>H-DJC52Z*>I]'D+[-K M@ R3?&UR"?U/OI.V[WZ[X3BV>M#O?\%NH]GZKC=<1(G9BN @EH&K]X9X? &I M362Y"JUQBW"J-IX22]2;ZR-:K*UDRA)$QHNE!:JB!9J MX^<0+?#V:4Z;Q!&H(!"T EJ!H0ZM(*P5F%G6DT6T; W!P%"'8$ PP"*D(FN; MBGP?Q>H.H3[O)#] *8@2?=K5WLSU0RI;@M/"MW9QPW-W,*$%$W-$-K^K#.*0 MGQX!W<&V-A4"(:M%R/7;-;%=&S@$#D'4:(C:GFVUFBUP$@L6((P01J8D9(X( MA)&B,+:VM8MW!0G)2A61V:Y>9GMX/0DR3Q]RF2SDQ)_Z$Z$>98X^6P0Y=WVJ MTW"T4_6B3)\]#J_*=K^FY\.*2&G3.PGV>R VYB\_B JR !!(""0!(D(@7T8@ M6U:K33";P(?8S)TM!)(?9I7D$002 DE1(-N636,W/*[$WJ:S7<^7/W#8HOV= MIRVN&\_.7W:C"=;"FMIJY?6_A5>?@F+V.2KFAI+>-0&@9)'ZKZN\B_GQ,?N\ M7GNR8@COV#[V_9OF5KESZZ6IOL]*.S0&K?,OM2',^'C(F[E9&I6*I1_-#V<' MS;?FX_N!>Q-EJ;K\M50L-;>RF\9ZQ1<4TP-WD M(Z7[(W-C]09BJ"SFT>!D54;!SMD,V6/D=0$ %=G[SH(%_!T_U3N6$SD?*]EK MV99PFLZVNG%J,A)H$)H2=&C9@0N&"[YU4*UOJO0DUUA1@+_CM M[<%J=0=-<+!>Z^-HV1IR [F!W-1#;GI6MT-BTV]:'&3N[2 WD!O(#>2&G-PX M5H_&1EJT.(@,*CE(6-'J/(TF?XE)-%_(,#'K.$0)_4^^D[;O?KOA.+9ZT.]_ MP6ZCV?JN-UQ$B:^?_R"6@7J1*_F-??V)[ !/:]PBFJJ-)T] & MA[C,2* WT!MJYF=N:>@-CID&BR 8S ' 4"BS'J?"3)'/#B2T>$ZG7-;Q'M:G29F:RPHB7;MZM4,AM>3(//\<":2A9SX4W\BU*/,L9DNHI2[+M%I.-HG M>E$V#B1IITAU$0R1,UF?#RM"G4W"/["M5HO$=E-<>+%^!I"!1 M]@U_>V4[K[X+L77C%;WO&\VN%M;45BNO_RV\^A0$L\]1,#>4\:X) "6+U']= MY5W,CX_9Y_7++@]9"1B%F$X;PICD(0*[61J53EH_FA_.#IIOS9#(A:M7C92&,0*:7_O5W3+@E9_X8S_PTYN# M\OL/5 /SV[7ZC=; >:TM^1#/BF=JV-W6DY]I/O4)I]%M=G[^,I5\F':/S,/8 M#:?W](BX?1E4HVL[Z00 WPW *O!L?U_@NF)V/L8)B@/AAV3E:H&B.G"@#(J%ISRZKV \W")!T>(_7[(W-C]09BJ"SFT>!D548! M#393@@ZUQ._RO]^9S:Y\',G(K?Y3NK&0='PJ=6AWSCQ,$1AY2 !05XFJ2FS( M2,J.Y43.QVJ*T+(MX32=;35+U&0DT" T)>@P2X +A@M>'PKG,'/Q++:3;W?*J M#X>'GT4L%U&<4JF%T4)SYZRK]P$Q6)6*T^]$XF#3&E1B.JD!'(#N:%F?N:6AMQL46Y^_=NUT[3;8%'-6$3+UA ,#'4( M!@0#+"++(EJVAF!@J$,P6 B&3FAM:XTU(PJQ2FBA1EC!&J%4)G7#B11NZ(DH MO92QF%RJEY9$=L.GA2TB#D0#9,4>O)(EJVAF!@J$,P(!A@$5D6T;(U M! -#'8(!P0"+R+*(EJTA&!CJ$ P6@H%%U;MF$$I8U2MAO7,]XK*(EJTA&!CJ$ P(!EA$ED6T; W!P%"'8$ PP"*R+*)E M:P@&ACH$@X5@8,W6KAF$>E7UZE7OHUC=(13R>G+IAC,I@BA)E 7V9JX?)MA* M"C$#-?,SMS1BANW&#-C*N68,HF5KB 6&.L2"A5A@5Q#^NX) ;B WD!O(#0.Y M00&LGBRB96L(!H8Z!(.%8&!ZLFL&?:, 9C=95,"*QR0X9]P=KT9S==-41%-Q MJ6XD8[$71%]E_$:D[K6(W51N]IRR;G^P_G^=Q8\=6M;[KG=__IEE^>C?:U?^ M<#;D#Q .SM^.U:=EO+*1HJ-(HL#WQ.UQ3 LFYH@\08GG8H+P2M5('%T*1K)C)%0-J@8.0=5(JIK=!B/!2*@: M"\3 (6J(0-5(JEJS#T9R8"16@E:O##Z\G@29YX98Z3]Q"D MW'6)3L/1/M&+LG$@23M%JHL7?J'!JN?#BDAGLY&.TP2M><0Z!%F).3SD$?)( M@(B0QY=*;Q-,!/"A-7-7"WGDAUDE>01YA#R2E$?,'B&/D$=&F%621Y!'R"-) M>>P07,C"A]:[*B2CLEA1\0, WPV ,K=ZA/"W5\XK@+%K, *@W '!'A, M "@W@# '1$" P @'H# '=$" P L#L OK$LI&]N_NH!TMC=[V/-NIV+[0Q_ M'$>%Q2T0"ZMKZY87_Q:N?:IUEN_/OO>_."GZMDGCY^K8+\1?V1N MG,I82&5'3QS+B9R/U:\MVQ).TW&$'^K%)\I0813N3]SD4KC>O[(DG:M+Z)T9 MDS2:_*7&S'PAP\35&_P)>:U_EL)-DFCBNZFZ[E<_O103A;#KAV(AXZE^R7#R M_[=W;4UM[$CX?7^%ZK DH(P-!E*GBG!"BJK=DVS(>=A'>4:VM34>320- MX'^_W9KQ!>-PAY'L?@G$S+1:??F^[AE9$NQC7U=A>_>_9L0U2+SB.C',CKAE ME\*@Y*30^,T8.Q+L9SF59LT(M!RY]8?I/?#SV C^"'X>1'X:>^P'Y"W$\%? M!7\ 9)C#C0HQK@1 R%#S#'&C7UB6R.3! )2I$G*:3F6 ,*D2QE.CYAK>H8H6 ML1IF8,Z$Y84V!>C K&)G)Q>?V,G%*3N(>NS=UE[G^,+).%V0X3Y^L)K+F"O& M>:HF K2#^(]'")4"XDFZ5YW"2BV<(?E0-!C$1CQBTID:G%'$UET&5LP!6,'; MZ80M?([FQ8UX84*Y,L(0[A+N$NZ&@+M[RV7?A=UEL%:18M!*F+K*'_6X4'EP$K]7&V#>_(C!K1;VY3SWN8\_.10P+E? M?V6?[07-WNAHBGOL$]T>M+3*TM S4SW.2C4:8[ZRU"]SC&;,D$-_4*;A+A^ MKD<\O>(34Y)$769;N1ZV?JMY%42OP4=]E2:+"+@NQ-#UHN>9>SJ(O>^F MF?;U3M ]SZ P5P51PUE+)_ M6^YR+J61?=>6'DWO/[Z]*5HY7&>OV>OUMM&>JTK82J=F]^#^:UKW7=%MMCK= MYXM92V7:#W#"33&T#UX8+Z;) 3XX8/Z$I_7&"V56F*;*!I.\A4'N*$I<%!*7D@(WE MLB?L3>XEX 7$>=/7F)]7KQ[Q(TO7)2YJSV\BPH!PF!S@"Q&^]99:PKW8D=!"9'$PLU)[2]"C( MG_7H+^7M+RK#WKWGJC5K_,3[LJ/_0]/NV5_&RG[C=Z MD1>;)?N5@X&C'=$-T0W1#=&-=W1ST#AL=2@'B6Z(;C8TU(ENB&[>C&YZA]3; M>'.\"ST_78_GIQ>W]Q^;NOZ9GE)=^3E]Z&A.N39$;#7CB@A*2%IB[<@/$8YY)M' MB-1\)+76(24D)2216A >HQSRS2-$:AZ2VCXU:D'D(SU37K]GRI^OX[1(\*1* MDXM8#F3,0)4QK6VE$F49$MO--F)BH@H\7MQG4/3U^V6>[*[T<+=2G?.RN\RV M.EYL^Q=J7@>.M<]-2VKAB1^)'SU(1.+'5]H6=[_7I;PF?B1^#,9G:YE'Q(_$ MCQ[RXV'7B[V$0LWJNAZ5T[/3->4^S@:$RE>W&W(P83_Y7&#L&$4P-P!*WCNT1U_B[8-P8%4MN0>Z5M",6@X>Y MS%@N] GF<7B8U]747OWOV;$-0B\XCHQS(ZX99?"H."DT+C6SHX$^UG.I%DS M "T';OU1>@_Z/#:^GHX^\)/W4^%^_95]MA4Y MWN2O-S8V0Y%IY6!22]WQZ!A\?,2Q#^^V]CK'W[^>G[I?=I@T#+0S^&XS87UN MX%^X#RS%AP)+CO>&]44JQ:"L NQ(EI7)EY.3;VPLN"F@3H#/"B,&10K5BZLT M7%EB%?P7QU?:,)XE"U+9U4ADKHCAKIS(M8(I\+Y,I9VX:[' $(.!C*7(XDE9 MSX!)8ZAJJJF,.*H&8L0X3]4$%8?*@%EP.)L>!(@Z*!"ER[$R*4R3_0#1GQ14 M-DX$Z <<*T=CC'G*/0HF:D"E ;^[C^)F1\/=R9)@X3]W$ MITIGPF(IJL:BZ75FWH=4+Y53!%(O#5(8S!"[!\WV-@9U(B"*$8,60AY#\R\( MQ*\0UF7&?7- P4X&V$+]X-<5H/WU]=O)CPK10.8_V_O-'@/E4L2A1%[*I)1\ M @@!$,1^*$207Z#C[*(92*+(O8-V\W F$_ +4L\-NZ@\Z.OR;9X]D&N0D*+L MYF#R6H$ F(C#&1B=Y6EA'$288HP#5;=9F%O5US7F%\\^P83&7Q?;OU08,_MP MCC-PFP-4%#@8B-@BP-]4;B9_=F$ILLD6;+$T3U295W\%M?L"(C;#F:$,:&X= MK",Z)N9]:137N8Y4"J@#'XF?!6+]\O31 8G/K0L+E?(+MD2< ]Y0Z M;!W1;;.Z@S,M!."/&;$SB&A_/4 =0@!AK^>QZV26\U*DJ>4W# ;:51: M]DD9,ICK*HJ5U?CTOEE7-1^[I+/&0KW18()KY&$L!31SSW$;#$>8>W#1N-FP M475I[E>XL&HFD,EC&+\B7,&A]>)8 2 QNR( )L%CP,W$3=UU:#CS6^;[=>.Q M:-!40D$ OIPTV;\A6K&7@]"6CN+O<9I7*33&%S2@R^VSF,^F<\0V]II(!H)>-[TJ>9HEUI85?37':/:V-8?&I'RAM,NQ6SSBZ16?F/+%:UUF M6[F$OWZK>15$KU%9]:'K?)VZ:IP7)6$@A_E8S+^=D5_O#.IS*'N@B(!+DQN[ MA+^=60_6T:Q_9[R BDLDRS9U;XU7+03AA573K\^@RE W';6.W>6[*9^HPL(8 MUR(Y+L>+6LX1U0TP^Y3G1AP9@?61%5,;.U0L9?^VO&CF4AI9OA8XFMZ_8I>F MN^*PZ;W6[W^6+J4X;VPO+Z]3PMY?/* M ;4M;%UAG9J<4UNU]E(NGJZ\^XPK[_Q(-=^]ZT?R$?H1^OF9'P&AWW\%)^@+ M"?JH0 \((,_\IM.KJ[E.P#M1JOM1:L;9D[ZVB?L!)'4]%Z5 MB)&(D8C11V*,6HUVY$53'F92!L6,U/VO7_=_'D3SL%_OF*I M)V\CZ#C/FMZ31XWHL$6)39T+G7<=C,_6,H^(((D@?23(3N.@0P09"$%Z=&J. MK]OKD3G('&2.$,T1UG[56UM;?AB3MD(/(-$>MNGKQ]_[*IG\\8^/OX_L./WC M_U!+ 0(4 Q0 ( !>(05;/2(J)[Q0 .\0 0 0 " 0 M !C;&(M,C R,S R,#$N:'1M4$L! A0#% @ %XA!5C9Q3<(/ P EPD M ! ( !'14 &-L8BTR,#(S,#(P,2YX